HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
116756.0,286913,2167-04-24 08:10:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2167-4-23**] 01:22 PM
   - HCT continued to trends down despite transfusion, had repeat CT scan
   which showed interval increase in size of hepatic/intraperitoneal
   hemorrhage, discussed with radiology and IR, will  aggressively
   transfuse for now
   - Received 4u pRBCs & hct went from 18 to 27
   (18--21--22
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-23**] 09:09 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2167-4-24**] 08:03 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.9
C (98.5
   HR: 92 (78 - 120) bpm
   BP: 177/88(112) {109/70(86) - 177/100(151)} mmHg
   RR: 20 (11 - 28) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  4,272 mL
                                                                  1,279 mL
   PO:
                                                                    100 mL
           TF:
   IVF:
                                                                  1,423 mL
                                                                     77 mL
   Blood products:
                                                                  1,510 mL
                                                                    549 mL
   Total out:
                                                                  1,650 mL
                                                                  1,375 mL
   Urine:
                                                                  1,650 mL
                                                                  1,375 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,622 mL
                                                                    -96 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 100%
   ABG: ///26/
   Physical Examination
   Labs / Radiology
   CT abd [**4-23**]:
   UNCHANGED Moderate amount of intraperitoneal fluid, particularly in a
   perisplenic location with slightly increased density, not seen on prior
    study
   and is suggestive of intraperitoneal hemorrhage from recent transjugula
   r liver
   biopsy.  The sentinel clot is larger now measuring 4x 7 cm compared to
   the
   prior when it measured
   58 K/uL
   10.3 g/dL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   27.4 %
   4.4 K/uL
        [image002.jpg]
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   Plt
   57
   46
   130
   107
   86
   58
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   [**4-21**]  Viral loads for CMV, HCV, HBV all neg
   [**4-23**] Liver Biopsy pending
   Assessment and Plan
   54 y.o. M with hx of recurrent multiple myeloma now s/p cord blood tx,
   Day +99 course c/b CMV viremia, BRBPR/diarrhea, ARF and low level
   hemolysis.
   .
   # s/p transjugular biopsy c/b bleed: with HCT drop, s/p 4u PRBCs
   overnight, CT abd showed stable hematoma,
   - serial HCT q4-6h, tranfuse for HCT less than 3 point drop
   - serial plts, goal transfusion plt ct>50
   - serial abdominal exam
   - surgery aware but would not go to OR for now
   - IR aware (page [**Numeric Identifier 1727**] , Dr. [**Last Name (STitle) 1728**] if needed)
   # Multiple myeloma s/p Cord Tranplant: Day +99, engrafted.  recent bone
   marrow day +79 <10% celllular, marked hypoplastic megakaryocytes.
   Chimerism: mostly donor so shouldn't be hemolysing
   - monitor cell counts - still transfusion dependent.
   - continue cellcept & methylpred
   - continue cyclosporin - lowered dose to 150mg [**Hospital1 **] on [**4-22**] - goal level
   200. f/u am cyclopsporin level & adjust prn
   .
   # BRBPR/Diarrhea: s/p EGD and colonoscopy that showed gastritis and
   previous duodenitis; Path negative for CMV/GVHD, also negative for
   evidence of amyloid. H. pylori positive, but will hold off on treating
   for now. Capusle studying demonstrated persistent bleeding in SB. No
   role for intervention at this time per GI recs. Pt with persistent
   diarrhea despite increased immunosuppression for presumed GVH.
   - Current immunosuppression regimen of cont solu-medrol 40mg [**Hospital1 **],
   cellcept 750mg IV BID, cyclosporin 150mg [**Hospital1 **]
   - continue sucralfate, pantoprazole
   - transfusion scales: keep hct>30 and platelets>30
   - rifaximin for possible bacterial overgrowth DC'd [**3-/2088**] due to concern
   for count suppression
   # Rising LFTs - possibly secondary to GVH given recent lowering of
   steroids corresponding to bump. past week increased LFT's, bili 1.3->
   3-> 5 (dbili 4). Also concern for CMV given previous viremia. Underwent
   transjugular liver biopsy on [**4-22**].
   - Abd US - WNL
   - Continue to monitor, TB 5 on [**4-22**]. Liver team consulted
   - will send hep panel, HSV, CMV pending
   - bx results pending
   # ARF: Cr stable 1.7-1.9. Likely multifactorial, including tacrolimus,
   cyclosporin toxicity, foscarnet, dehydration [**3-7**] chronic diarrhea,
   amyloidosis. Renal U/S negative. UPEP, SPEP negative.
   - monitor Cr
   - continue IVF PRN
   .
   # ID: afebrile: during course has been switched from foscarnet to
   valgancicovir, now to acyclovir due to renal insufficiency. Recent CMV
   VL negative. s/p multifocal PNA treated with vanc/cefpemine with
   resolution. Also during hospitalization developed Capnocytophaga (gram
   negative rod) on a blood culture drawn early in his course ([**1-19**]).
   Repeat blood cultures have been negative.
   - CXR with ? new infiltrate
   - consider atorvoquane as outpatient for PCP [**Name Initial (PRE) **]. Received pentamidine
   on [**4-15**]
   - started levaquin for atypical coverage given intermittent low grade
   fevers on [**4-22**], but will stop given low clinical suspicion
   - glucan and galactomannan pending
   .
   # CMV Viremia: CMV VL negative since mid-[**Month (only) **]. Duodenal and colonic
   CMV stains negative. CMV VL negative from [**3-23**]. Initially on
   valgancyclovir, then switched to foscarnet [**3-7**] renal failure and now
   recently switched to acyclovir
   - appreciate ID consult continue ACV 400 [**Hospital1 **] for CMV ppx indefinitely
   (at least 1 year)
   - CMV VL q5 days - all recent VL negative
   - cont. acyclovir
   .
   # HTN: slightly hypertensive
   - continue Norvasc &  labetalol 400 mg TID
   .
   # Nausea:
   - continue compazine
   - monitor symptoms
   .
   # Diabetes: Hyperglycemic with steroids
   - Continue ISS and insulin in TPN
   ICU Care
   Nutrition: TPN w/ Lipids - [**2167-4-24**] 06:34 AM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Tunneled (Hickman) Line - [**2167-4-23**] 01:22 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI, Sucralfate
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2167-4-23**] 01:22 PM
   - HCT continued to trends down despite transfusion, had repeat CT scan
   which showed interval increase in size of hepatic/intraperitoneal
   hemorrhage, discussed with radiology and IR, will  aggressively
   transfuse for now
   - Received 4u pRBCs & hct went from 18 to 27
   (18--21--22
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-23**] 09:09 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2167-4-24**] 08:03 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.9
C (98.5
   HR: 92 (78 - 120) bpm
   BP: 177/88(112) {109/70(86) - 177/100(151)} mmHg
   RR: 20 (11 - 28) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  4,272 mL
                                                                  1,279 mL
   PO:
                                                                    100 mL
           TF:
   IVF:
                                                                  1,423 mL
                                                                     77 mL
   Blood products:
                                                                  1,510 mL
                                                                    549 mL
   Total out:
                                                                  1,650 mL
                                                                  1,375 mL
   Urine:
                                                                  1,650 mL
                                                                  1,375 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,622 mL
                                                                    -96 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 100%
   ABG: ///26/
   Physical Examination
   Labs / Radiology
   CT abd [**4-23**]:
   UNCHANGED Moderate amount of intraperitoneal fluid, particularly in a
   perisplenic location with slightly increased density, not seen on prior
    study
   and is suggestive of intraperitoneal hemorrhage from recent transjugula
   r liver
   biopsy.  The sentinel clot is larger now measuring 4x 7 cm compared to
   the
   prior when it measured
   58 K/uL
   10.3 g/dL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   27.4 %
   4.4 K/uL
        [image002.jpg]
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   Plt
   57
   46
   130
   107
   86
   58
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   [**4-21**]  Viral loads for CMV, HCV, HBV all neg
   [**4-23**] Liver Biopsy pending
   Assessment and Plan
   54 y.o. M with hx of recurrent multiple myeloma now s/p cord blood tx,
   Day +99 course c/b CMV viremia, BRBPR/diarrhea, ARF and low level
   hemolysis.
   .
   # s/p transjugular biopsy c/b bleed: with HCT drop, s/p 4u PRBCs
   overnight, CT abd showed stable hematoma,
   - serial HCT q4-6h, tranfuse for HCT less than 3 point drop
   - serial plts, goal transfusion plt ct>50
   - serial abdominal exam
   - surgery aware but would not go to OR for now
   - IR aware (page [**Numeric Identifier 1727**] , Dr. [**Last Name (STitle) 1728**] if needed)
   # Multiple myeloma s/p Cord Tranplant: Day +99, engrafted.  recent bone
   marrow day +79 <10% celllular, marked hypoplastic megakaryocytes.
   Chimerism: mostly donor so shouldn't be hemolysing
   - monitor cell counts - still transfusion dependent.
   - continue cellcept & methylpred
   - continue cyclosporin - lowered dose to 150mg [**Hospital1 **] on [**4-22**] - goal level
   200. f/u am cyclopsporin level & adjust prn
   .
   # BRBPR/Diarrhea: s/p EGD and colonoscopy that showed gastritis and
   previous duodenitis; Path negative for CMV/GVHD, also negative for
   evidence of amyloid. H. pylori positive, but will hold off on treating
   for now. Capusle studying demonstrated persistent bleeding in SB. No
   role for intervention at this time per GI recs. Pt with persistent
   diarrhea despite increased immunosuppression for presumed GVH.
   - Current immunosuppression regimen of cont solu-medrol 40mg [**Hospital1 **],
   cellcept 750mg IV BID, cyclosporin 150mg [**Hospital1 **]
   - continue sucralfate, pantoprazole
   - transfusion scales: keep hct>30 and platelets>30
   - rifaximin for possible bacterial overgrowth DC'd [**3-/2088**] due to concern
   for count suppression
   # Rising LFTs - possibly secondary to GVH given recent lowering of
   steroids corresponding to bump. past week increased LFT's, bili 1.3->
   3-> 5 (dbili 4). Also concern for CMV given previous viremia. Underwent
   transjugular liver biopsy on [**4-22**].
   - Abd US - WNL
   - Continue to monitor, TB 5 on [**4-22**]. Liver team consulted
   - will send hep panel, HSV, CMV pending
   - bx results pending
   # ARF: Cr stable 1.7-1.9. Likely multifactorial, including tacrolimus,
   cyclosporin toxicity, foscarnet, dehydration [**3-7**] chronic diarrhea,
   amyloidosis. Renal U/S negative. UPEP, SPEP negative.
   - monitor Cr
   - continue IVF PRN
   .
   # ID: afebrile: during course has been switched from foscarnet to
   valgancicovir, now to acyclovir due to renal insufficiency. Recent CMV
   VL negative. s/p multifocal PNA treated with vanc/cefpemine with
   resolution. Also during hospitalization developed Capnocytophaga (gram
   negative rod) on a blood culture drawn early in his course ([**1-19**]).
   Repeat blood cultures have been negative.
   - CXR with ? new infiltrate
   - consider atorvoquane as outpatient for PCP [**Name Initial (PRE) **]. Received pentamidine
   on [**4-15**]
   - started levaquin for atypical coverage given intermittent low grade
   fevers on [**4-22**], but will stop given low clinical suspicion
   - glucan and galactomannan pending
   .
   # CMV Viremia: CMV VL negative since mid-[**Month (only) **]. Duodenal and colonic
   CMV stains negative. CMV VL negative from [**3-23**]. Initially on
   valgancyclovir, then switched to foscarnet [**3-7**] renal failure and now
   recently switched to acyclovir
   - appreciate ID consult continue ACV 400 [**Hospital1 **] for CMV ppx indefinitely
   (at least 1 year)
   - CMV VL q5 days - all recent VL negative
   - cont. acyclovir
   .
   # HTN: slightly hypertensive
   - continue Norvasc &  labetalol 400 mg TID
   .
   # Nausea:
   - continue compazine
   - monitor symptoms
   .
   # Diabetes: Hyperglycemic with steroids
   - Continue ISS and insulin in TPN
   ICU Care
   Nutrition: TPN w/ Lipids - [**2167-4-24**] 06:34 AM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Tunneled (Hickman) Line - [**2167-4-23**] 01:22 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI, Sucralfate
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following potential medical complications can arise:

1. Hemorrhagic shock: The patient's HCT trended down despite transfusion, and the CT scan showed an increase in the size of the hepatic/intraperitoneal hemorrhage. Aggressive transfusion is necessary to prevent further bleeding and potential shock.
2. Renal failure: The patient's creatinine levels are stable at 1.7-1.9, and the patient is at risk of developing acute kidney injury (AKI) due to the combination of medications, including tacrolimus and cyclosporin, and potential dehydration.
3. Gastrointestinal bleeding: The patient has a history of recurrent bleeding in the stomach and duodenum, and the recent colonoscopy and endoscopy showed gastritis and duodenitis. The patient is at risk of further bleeding, particularly with the continued use of immunosuppressive medications.
4. Infections: The patient has a history of CMV viremia and has received multiple antibiotics, including vancomycin and cefepime. The patient is at risk of developing further infections, particularly with the continued use of immunosuppressive medications.
5. Hepatic dysfunction: The patient's liver enzymes are elevated, and the patient is at risk of developing further liver damage due to the combination of medications, including tacrolimus and cyclosporin, and potential GVHD.
6. Hyperglycemia: The patient is at risk of developing hyperglycemia due to the use of steroids and other medications, and the patient's glucose levels should be closely monitored.
7. Hypertension: The patient is at risk of developing hypertension due to the use of immunosuppressive medications and the patient's blood pressure should be closely monitored.

In terms of the patient's current status, the patient is critically ill and requires close monitoring and management. The patient's HCT is still trending down, and the patient is at risk of further bleeding. The patient's creatinine levels are stable, but the patient is at risk of developing AKI. The patient's liver enzymes are elevated, and the patient is at risk of developing further liver damage. The patient's glucose levels are elevated, and the patient is at risk of developing hyperglycemia. The patient's blood pressure is slightly elevated, and the patient is at risk of developing hypertension.

The patient's treatment plan should include close monitoring of the patient's HCT, creatinine levels, liver enzymes, glucose levels, and blood pressure. The patient should receive aggressive transfusion to prevent further bleeding and potential shock. The patient's immunosuppressive medications should be closely monitored, and the patient should receive prophylaxis for DVT and stress ulcer. The patient's nutrition should be closely monitored, and the patient should receive TPN with lipids."
116756.0,286913,2167-04-24 08:10:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2167-4-23**] 01:22 PM
   - HCT continued to trends down despite transfusion, had repeat CT scan
   which showed interval increase in size of hepatic/intraperitoneal
   hemorrhage, discussed with radiology and IR, will  aggressively
   transfuse for now
   - Received 4u pRBCs & hct went from 18 to 27
   (18--21--22
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-23**] 09:09 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2167-4-24**] 08:03 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.9
C (98.5
   HR: 92 (78 - 120) bpm
   BP: 177/88(112) {109/70(86) - 177/100(151)} mmHg
   RR: 20 (11 - 28) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  4,272 mL
                                                                  1,279 mL
   PO:
                                                                    100 mL
           TF:
   IVF:
                                                                  1,423 mL
                                                                     77 mL
   Blood products:
                                                                  1,510 mL
                                                                    549 mL
   Total out:
                                                                  1,650 mL
                                                                  1,375 mL
   Urine:
                                                                  1,650 mL
                                                                  1,375 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,622 mL
                                                                    -96 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 100%
   ABG: ///26/
   Physical Examination
   GEN: NAD, comfortable, tremulous all four extremities
   HEENT: skin with scattered dark spots, no frank scleral icterus
   CV: RRR no m/r/g
   RESP: CTAB no w/r
   ABD: TTP over RUQ, no flank bruising or eccymosis noted
   EXTR: trace pitting edema bilaterally
   Labs / Radiology
   CT abd [**4-23**]:
   UNCHANGED Moderate amount of intraperitoneal fluid, particularly in a
   perisplenic location with slightly increased density, not seen on prior
    study
   and is suggestive of intraperitoneal hemorrhage from recent transjugula
   r liver
   biopsy.  The sentinel clot is larger now measuring 4x 7 cm compared to
   the
   prior when it measured
   58 K/uL
   10.3 g/dL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   27.4 %
   4.4 K/uL
        [image002.jpg]
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   Plt
   57
   46
   130
   107
   86
   58
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   [**4-21**]  Viral loads for CMV, HCV, HBV all neg
   [**4-23**] Liver Biopsy pending
   Assessment and Plan
   54 y.o. M with hx of recurrent multiple myeloma now Day 99 s/p cord
   blood transplant course c/b CMV viremia, GVHD in liver & colon, ARF and
   low level hemolysis.
   .
   # s/p transjugular biopsy c/b bleed: with HCT drop, s/p 4u PRBCs
   overnight, CT abd showed increasing perihepatic hematoma, hct bumped
   approp this am & f/u hct stable.
   - f/u HCT q6hr, transfusion goal 27-30
   - serial plts, goal transfusion plt ct>50-75
   - serial abd exams
   - surgery & IR aware (page [**Numeric Identifier 1727**] , Dr. [**Last Name (STitle) 1728**] if needed) no plan for
   acute intervention
   - starting Ms Contin 15mg [**Hospital1 **] with breakthrough morphine prn
   # Multiple myeloma Day 99 s/p Cord Tranplant: recent bone marrow day
   +79 <10% celllular, marked hypoplastic megakaryocytes. Chimerism:
   mostly donor so shouldn't be hemolysing.
   - monitor cell counts - still transfusion dependent (goal plts >50 &
   goal hct >27-30)
   - continue cellcept & methylpred
   - continue cyclosporin [**Month (only) 38**] to 150mg [**Hospital1 **]
   - f/u am cyclopsporin level & adjust prn for goal 200
   .
   # BRBPR/Diarrhea: recent EGD with e/o gastritis/duodenitis, path neg
   for CMV/GVHD. H. pylori Ab+, capsule showed persistent bleeding in SB,
   no intervention at this time per GI.  Pt with persistent diarrhea
   despite increased immunosuppression for presumed GVH.  Currently on TPN
   & clears for bowel rest
   - current regimen of solu-medrol 40mg [**Hospital1 **], cellcept 750mg IV BID,
   cyclosporin 150mg [**Hospital1 **]
   - continue sucralfate, pantoprazole
   - transfusion scales: keep hct>30 and platelets>30
   # Rising LFTs
 likely [**3-7**] to GVH given [**4-22**] liver biopsy positive, all
   viral studies negative ( CMV, HBV, HCV)
   - trend LFTs daily
   - f/u final path report, immune suppression per BMT
   # ARF: Cr up slightly from baseline of 1.9 to 2.0. Likely
   multifactorial, including tacrolimus, cyclosporin toxicity, foscarnet,
   dehydration [**3-7**] chronic diarrhea  & drop in hct. Renal U/S negative.
   UPEP, SPEP negative.
   - monitor Creatinine & trend daily
   .
   # CMV Viremia: repeat CMV VL have been negative through [**Month (only) **]/[**Month (only) **], but
   was initially treated with valgancyclovir, then switched to foscarnet
   [**3-7**] renal failure and now recently on acyclovir. Per BMT, holding
   Acyclovir for a few days given slight rise in creatinine, will restart
   on [**4-27**]
   - per ID (would plan to continue Acyclovir 400 [**Hospital1 **] for CMV ppx at least
   1 year)
   - CMV VL q5 days - all recent VL negative
   .
   # HTN: slightly hypertensive
   - continue Norvasc &  labetalol 400 mg TID
   .  .
   # Diabetes: Hyperglycemic with steroids
   - Continue ISS and insulin in TPN
   ICU Care
   Nutrition: TPN w/ Lipids - [**2167-4-24**] 06:34 AM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines: Tunneled (Hickman) Line - [**2167-4-23**] 01:22 PM
   Prophylaxis:  DVT: Boots
   Stress ulcer: PPI, Sucralfate
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2167-4-23**] 01:22 PM
   - HCT continued to trends down despite transfusion, had repeat CT scan
   which showed interval increase in size of hepatic/intraperitoneal
   hemorrhage, discussed with radiology and IR, will  aggressively
   transfuse for now
   - Received 4u pRBCs & hct went from 18 to 27
   (18--21--22
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-23**] 09:09 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2167-4-24**] 08:03 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.9
C (98.5
   HR: 92 (78 - 120) bpm
   BP: 177/88(112) {109/70(86) - 177/100(151)} mmHg
   RR: 20 (11 - 28) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  4,272 mL
                                                                  1,279 mL
   PO:
                                                                    100 mL
           TF:
   IVF:
                                                                  1,423 mL
                                                                     77 mL
   Blood products:
                                                                  1,510 mL
                                                                    549 mL
   Total out:
                                                                  1,650 mL
                                                                  1,375 mL
   Urine:
                                                                  1,650 mL
                                                                  1,375 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,622 mL
                                                                    -96 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 100%
   ABG: ///26/
   Physical Examination
   GEN: NAD, comfortable, tremulous all four extremities
   HEENT: skin with scattered dark spots, no frank scleral icterus
   CV: RRR no m/r/g
   RESP: CTAB no w/r
   ABD: TTP over RUQ, no flank bruising or eccymosis noted
   EXTR: trace pitting edema bilaterally
   Labs / Radiology
   CT abd [**4-23**]:
   UNCHANGED Moderate amount of intraperitoneal fluid, particularly in a
   perisplenic location with slightly increased density, not seen on prior
    study
   and is suggestive of intraperitoneal hemorrhage from recent transjugula
   r liver
   biopsy.  The sentinel clot is larger now measuring 4x 7 cm compared to
   the
   prior when it measured
   58 K/uL
   10.3 g/dL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   27.4 %
   4.4 K/uL
        [image002.jpg]
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   Plt
   57
   46
   130
   107
   86
   58
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   [**4-21**]  Viral loads for CMV, HCV, HBV all neg
   [**4-23**] Liver Biopsy pending
   Assessment and Plan
   54 y.o. M with hx of recurrent multiple myeloma now Day 99 s/p cord
   blood transplant course c/b CMV viremia, GVHD in liver & colon, ARF and
   low level hemolysis.
   .
   # s/p transjugular biopsy c/b bleed: with HCT drop, s/p 4u PRBCs
   overnight, CT abd showed increasing perihepatic hematoma, hct bumped
   approp this am & f/u hct stable.
   - f/u HCT q6hr, transfusion goal 27-30
   - serial plts, goal transfusion plt ct>50-75
   - serial abd exams
   - surgery & IR aware (page [**Numeric Identifier 1727**] , Dr. [**Last Name (STitle) 1728**] if needed) no plan for
   acute intervention
   - starting Ms Contin 15mg [**Hospital1 **] with breakthrough morphine prn
   # Multiple myeloma Day 99 s/p Cord Tranplant: recent bone marrow day
   +79 <10% celllular, marked hypoplastic megakaryocytes. Chimerism:
   mostly donor so shouldn't be hemolysing.
   - monitor cell counts - still transfusion dependent (goal plts >50 &
   goal hct >27-30)
   - continue cellcept & methylpred
   - continue cyclosporin [**Month (only) 38**] to 150mg [**Hospital1 **]
   - f/u am cyclopsporin level & adjust prn for goal 200
   .
   # BRBPR/Diarrhea: recent EGD with e/o gastritis/duodenitis, path neg
   for CMV/GVHD. H. pylori Ab+, capsule showed persistent bleeding in SB,
   no intervention at this time per GI.  Pt with persistent diarrhea
   despite increased immunosuppression for presumed GVH.  Currently on TPN
   & clears for bowel rest
   - current regimen of solu-medrol 40mg [**Hospital1 **], cellcept 750mg IV BID,
   cyclosporin 150mg [**Hospital1 **]
   - continue sucralfate, pantoprazole
   - transfusion scales: keep hct>30 and platelets>30
   # Rising LFTs
 likely [**3-7**] to GVH given [**4-22**] liver biopsy positive, all
   viral studies negative ( CMV, HBV, HCV)
   - trend LFTs daily
   - f/u final path report, immune suppression per BMT
   # ARF: Cr up slightly from baseline of 1.9 to 2.0. Likely
   multifactorial, including tacrolimus, cyclosporin toxicity, foscarnet,
   dehydration [**3-7**] chronic diarrhea  & drop in hct. Renal U/S negative.
   UPEP, SPEP negative.
   - monitor Creatinine & trend daily
   .
   # CMV Viremia: repeat CMV VL have been negative through [**Month (only) **]/[**Month (only) **], but
   was initially treated with valgancyclovir, then switched to foscarnet
   [**3-7**] renal failure and now recently on acyclovir. Per BMT, holding
   Acyclovir for a few days given slight rise in creatinine, will restart
   on [**4-27**]
   - per ID (would plan to continue Acyclovir 400 [**Hospital1 **] for CMV ppx at least
   1 year)
   - CMV VL q5 days - all recent VL negative
   .
   # HTN: slightly hypertensive
   - continue Norvasc &  labetalol 400 mg TID
   .  .
   # Diabetes: Hyperglycemic with steroids
   - Continue ISS and insulin in TPN
   ICU Care
   Nutrition: TPN w/ Lipids - [**2167-4-24**] 06:34 AM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines: Tunneled (Hickman) Line - [**2167-4-23**] 01:22 PM
   Prophylaxis:  DVT: Boots
   Stress ulcer: PPI, Sucralfate
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 54-year-old male with a history of recurrent multiple myeloma who underwent a cord blood transplant 99 days prior. He is currently in the ICU due to a decline in his hemoglobin level, leading to a transfusion of 4 units of packed red blood cells. A repeat CT scan showed an increase in the size of the hepatic/intraperitoneal hemorrhage, and he is being aggressively transfused.

The patient has multiple medical conditions, including:

* CMV viremia, which was initially treated with valgancyclovir, then switched to foscarnet due to renal failure, and is now on acyclovir
* GVHD in the liver and colon
* ARF, which is likely multifactorial and includes tacrolimus and cyclosporin toxicity
* Low-level hemolysis
* Hypertension
* Hyperglycemia due to steroids
* Rising LFTs, which are likely related to GVH

The patient is currently receiving treatment with:

* Ms Contin for breakthrough morphine
* Cyclosporin to 150mg
* Cellcept
* Methylprednisolone
* Solu-medrol
* Pantoprazole
* Sucralfate
* TPN with lipids
* Regular insulin sliding scale
* Prophylactic DVT boots
* Stress ulcer prophylaxis

Potential medical complications that can arise include:

* Further bleeding due to the hepatic/intraperitoneal hemorrhage
* Increased risk of infection due to the patient's immunosuppressed state
* Renal failure due to the patient's pre-existing kidney disease and potential toxicity from immunosuppressive medications
* Gastrointestinal bleeding due to the patient's gastritis and duodenitis
* Hypertensive crisis due to the patient's hypertension and potential toxicity from immunosuppressive medications
* Hyperglycemic crisis due to the patient's diabetes and potential toxicity from immunosuppressive medications
* Liver failure due to the patient's GVHD and potential toxicity from immunosuppressive medications."
116756.0,286913,2167-04-24 08:10:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2167-4-23**] 01:22 PM
   - HCT continued to trends down despite transfusion, had repeat CT scan
   which showed interval increase in size of hepatic/intraperitoneal
   hemorrhage, discussed with radiology and IR, will  aggressively
   transfuse for now
   - Received 4u pRBCs & hct went from 18 to 27
   (18--21--22
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-23**] 09:09 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2167-4-24**] 08:03 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.9
C (98.5
   HR: 92 (78 - 120) bpm
   BP: 177/88(112) {109/70(86) - 177/100(151)} mmHg
   RR: 20 (11 - 28) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  4,272 mL
                                                                  1,279 mL
   PO:
                                                                    100 mL
           TF:
   IVF:
                                                                  1,423 mL
                                                                     77 mL
   Blood products:
                                                                  1,510 mL
                                                                    549 mL
   Total out:
                                                                  1,650 mL
                                                                  1,375 mL
   Urine:
                                                                  1,650 mL
                                                                  1,375 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,622 mL
                                                                    -96 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 100%
   ABG: ///26/
   Physical Examination
   GEN: NAD, comfortable, tremulous all four extremities
   HEENT: skin with scattered dark spots, no frank scleral icterus
   CV: RRR no m/r/g
   RESP: CTAB no w/r
   ABD: TTP over RUQ, no flank bruising or eccymosis noted
   EXTR: trace pitting edema bilaterally
   Labs / Radiology
   CT abd [**4-23**]:
   UNCHANGED Moderate amount of intraperitoneal fluid, particularly in a
   perisplenic location with slightly increased density, not seen on prior
    study
   and is suggestive of intraperitoneal hemorrhage from recent transjugula
   r liver
   biopsy.  The sentinel clot is larger now measuring 4x 7 cm compared to
   the
   prior when it measured
   58 K/uL
   10.3 g/dL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   27.4 %
   4.4 K/uL
        [image002.jpg]
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   Plt
   57
   46
   130
   107
   86
   58
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   [**4-21**]  Viral loads for CMV, HCV, HBV all neg
   [**4-23**] Liver Biopsy pending
   Assessment and Plan
   54 y.o. M with hx of recurrent multiple myeloma now Day 99 s/p cord
   blood transplant course c/b CMV viremia, GVHD in liver & colon, ARF and
   low level hemolysis.
   .
   # s/p transjugular biopsy c/b bleed: with HCT drop, s/p 4u PRBCs
   overnight, CT abd showed increasing perihepatic hematoma, hct bumped
   approp this am & f/u hct stable
   - f/u HCT q6hr, transfusion goal 27-30
   - serial plts, goal transfusion plt ct>50-75
   - serial abd exam
   - surgery & IR aware (page [**Numeric Identifier 1727**] , Dr. [**Last Name (STitle) 1728**] if needed) no plan for
   acute intervention
   - starting Ms Contin 15mg [**Hospital1 **] with breakthrough prn
   # Multiple myeloma Day 99 s/p Cord Tranplant: recent bone marrow day
   +79 <10% celllular, marked hypoplastic megakaryocytes. Chimerism:
   mostly donor so shouldn't be hemolysing.
   - monitor cell counts - still transfusion dependent (goal plts >50 &
   goal hct >27-30)
   - continue cellcept & methylpred
   - continue cyclosporin - lowered dose to 150mg [**Hospital1 **] on [**4-22**] - goal level
   200. f/u am cyclopsporin level & adjust prn
   .
   # BRBPR/Diarrhea: recent EGD with e/o gastritis/duodenitis, path
   negative for CMV/GVHD. H. pylori positive, but will hold off on
   treatment for now. Capsule showed persistent bleeding in SB. No role
   for intervention at this time per GI recs. Pt with persistent diarrhea
   despite increased immunosuppression for presumed GVH.  Currently on TPN
   & clears for bowel rest
   - Current immunosuppression regimen of cont solu-medrol 40mg [**Hospital1 **],
   cellcept 750mg IV BID, cyclosporin 150mg [**Hospital1 **]
   - continue sucralfate, pantoprazole
   - transfusion scales: keep hct>30 and platelets>30
   - rifaximin DC'd [**3-/2088**] due to concern for count suppression
   # Rising LFTs
 likely [**3-7**] to GVH given [**4-22**] liver biopsy positive, all
   viral studies negative ( CMV, HBV, HCV)
   - trend LFTs daily, TB 5 on [**4-22**]. Liver team consulted
   - f/u final path report, immune suppression per BMT
   # ARF: Cr up slightly from baseline of 1.9 to 2.0. Likely
   multifactorial, including tacrolimus, cyclosporin toxicity, foscarnet,
   dehydration [**3-7**] chronic diarrhea  & drop in hct. Renal U/S negative.
   UPEP, SPEP negative.
   - monitor Creatinine & trend daily
   .
   # ID: Pt currently afebrile & sating well on RA. S/p multifocal PNA
   treated with vanc/cefpemine with resolution.  Suggestion of infiltrate
   on CT lung bases, but CXR clear & no pulm symptoms. D/c
d Levaquin.
   - continue to monitor symptoms
   - consider atorvoquane as outpatient for PCP [**Name Initial (PRE) **]. Received pentamidine
   on [**4-15**]
   - glucan and galactomannan pending
   .
   # CMV Viremia: CMV VL negative since mid-[**Month (only) **]. Duodenal and colonic
   CMV stains negative. CMV VL negative from [**3-23**]. Initially on
   valgancyclovir, then switched to foscarnet [**3-7**] renal failure and now
   recently switched to acyclovir
   - appreciate ID consult continue ACV 400 [**Hospital1 **] for CMV ppx indefinitely
   (at least 1 year)
   - CMV VL q5 days - all recent VL negative
   - cont. acyclovir
   .
   # HTN: slightly hypertensive
   - continue Norvasc &  labetalol 400 mg TID
   .
   # Nausea:
   - continue compazine
   - monitor symptoms
   .
   # Diabetes: Hyperglycemic with steroids
   - Continue ISS and insulin in TPN
   ICU Care
   Nutrition: TPN w/ Lipids - [**2167-4-24**] 06:34 AM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines: Tunneled (Hickman) Line - [**2167-4-23**] 01:22 PM
   Prophylaxis:  DVT: Boots
   Stress ulcer: PPI, Sucralfate
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2167-4-23**] 01:22 PM
   - HCT continued to trends down despite transfusion, had repeat CT scan
   which showed interval increase in size of hepatic/intraperitoneal
   hemorrhage, discussed with radiology and IR, will  aggressively
   transfuse for now
   - Received 4u pRBCs & hct went from 18 to 27
   (18--21--22
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-23**] 09:09 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2167-4-24**] 08:03 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.9
C (98.5
   HR: 92 (78 - 120) bpm
   BP: 177/88(112) {109/70(86) - 177/100(151)} mmHg
   RR: 20 (11 - 28) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  4,272 mL
                                                                  1,279 mL
   PO:
                                                                    100 mL
           TF:
   IVF:
                                                                  1,423 mL
                                                                     77 mL
   Blood products:
                                                                  1,510 mL
                                                                    549 mL
   Total out:
                                                                  1,650 mL
                                                                  1,375 mL
   Urine:
                                                                  1,650 mL
                                                                  1,375 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,622 mL
                                                                    -96 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 100%
   ABG: ///26/
   Physical Examination
   GEN: NAD, comfortable, tremulous all four extremities
   HEENT: skin with scattered dark spots, no frank scleral icterus
   CV: RRR no m/r/g
   RESP: CTAB no w/r
   ABD: TTP over RUQ, no flank bruising or eccymosis noted
   EXTR: trace pitting edema bilaterally
   Labs / Radiology
   CT abd [**4-23**]:
   UNCHANGED Moderate amount of intraperitoneal fluid, particularly in a
   perisplenic location with slightly increased density, not seen on prior
    study
   and is suggestive of intraperitoneal hemorrhage from recent transjugula
   r liver
   biopsy.  The sentinel clot is larger now measuring 4x 7 cm compared to
   the
   prior when it measured
   58 K/uL
   10.3 g/dL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   27.4 %
   4.4 K/uL
        [image002.jpg]
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   Plt
   57
   46
   130
   107
   86
   58
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   [**4-21**]  Viral loads for CMV, HCV, HBV all neg
   [**4-23**] Liver Biopsy pending
   Assessment and Plan
   54 y.o. M with hx of recurrent multiple myeloma now Day 99 s/p cord
   blood transplant course c/b CMV viremia, GVHD in liver & colon, ARF and
   low level hemolysis.
   .
   # s/p transjugular biopsy c/b bleed: with HCT drop, s/p 4u PRBCs
   overnight, CT abd showed increasing perihepatic hematoma, hct bumped
   approp this am & f/u hct stable
   - f/u HCT q6hr, transfusion goal 27-30
   - serial plts, goal transfusion plt ct>50-75
   - serial abd exam
   - surgery & IR aware (page [**Numeric Identifier 1727**] , Dr. [**Last Name (STitle) 1728**] if needed) no plan for
   acute intervention
   - starting Ms Contin 15mg [**Hospital1 **] with breakthrough prn
   # Multiple myeloma Day 99 s/p Cord Tranplant: recent bone marrow day
   +79 <10% celllular, marked hypoplastic megakaryocytes. Chimerism:
   mostly donor so shouldn't be hemolysing.
   - monitor cell counts - still transfusion dependent (goal plts >50 &
   goal hct >27-30)
   - continue cellcept & methylpred
   - continue cyclosporin - lowered dose to 150mg [**Hospital1 **] on [**4-22**] - goal level
   200. f/u am cyclopsporin level & adjust prn
   .
   # BRBPR/Diarrhea: recent EGD with e/o gastritis/duodenitis, path
   negative for CMV/GVHD. H. pylori positive, but will hold off on
   treatment for now. Capsule showed persistent bleeding in SB. No role
   for intervention at this time per GI recs. Pt with persistent diarrhea
   despite increased immunosuppression for presumed GVH.  Currently on TPN
   & clears for bowel rest
   - Current immunosuppression regimen of cont solu-medrol 40mg [**Hospital1 **],
   cellcept 750mg IV BID, cyclosporin 150mg [**Hospital1 **]
   - continue sucralfate, pantoprazole
   - transfusion scales: keep hct>30 and platelets>30
   - rifaximin DC'd [**3-/2088**] due to concern for count suppression
   # Rising LFTs
 likely [**3-7**] to GVH given [**4-22**] liver biopsy positive, all
   viral studies negative ( CMV, HBV, HCV)
   - trend LFTs daily, TB 5 on [**4-22**]. Liver team consulted
   - f/u final path report, immune suppression per BMT
   # ARF: Cr up slightly from baseline of 1.9 to 2.0. Likely
   multifactorial, including tacrolimus, cyclosporin toxicity, foscarnet,
   dehydration [**3-7**] chronic diarrhea  & drop in hct. Renal U/S negative.
   UPEP, SPEP negative.
   - monitor Creatinine & trend daily
   .
   # ID: Pt currently afebrile & sating well on RA. S/p multifocal PNA
   treated with vanc/cefpemine with resolution.  Suggestion of infiltrate
   on CT lung bases, but CXR clear & no pulm symptoms. D/c
d Levaquin.
   - continue to monitor symptoms
   - consider atorvoquane as outpatient for PCP [**Name Initial (PRE) **]. Received pentamidine
   on [**4-15**]
   - glucan and galactomannan pending
   .
   # CMV Viremia: CMV VL negative since mid-[**Month (only) **]. Duodenal and colonic
   CMV stains negative. CMV VL negative from [**3-23**]. Initially on
   valgancyclovir, then switched to foscarnet [**3-7**] renal failure and now
   recently switched to acyclovir
   - appreciate ID consult continue ACV 400 [**Hospital1 **] for CMV ppx indefinitely
   (at least 1 year)
   - CMV VL q5 days - all recent VL negative
   - cont. acyclovir
   .
   # HTN: slightly hypertensive
   - continue Norvasc &  labetalol 400 mg TID
   .
   # Nausea:
   - continue compazine
   - monitor symptoms
   .
   # Diabetes: Hyperglycemic with steroids
   - Continue ISS and insulin in TPN
   ICU Care
   Nutrition: TPN w/ Lipids - [**2167-4-24**] 06:34 AM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines: Tunneled (Hickman) Line - [**2167-4-23**] 01:22 PM
   Prophylaxis:  DVT: Boots
   Stress ulcer: PPI, Sucralfate
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 54-year-old male with a history of recurrent multiple myeloma, who underwent a cord blood transplant 99 days ago. He is currently experiencing several complications, including:

1. Intraperitoneal hemorrhage: The patient has a large perihepatic hematoma, which is increasing in size, and is causing a drop in his hemoglobin and hematocrit levels.
2. Low platelet count: The patient's platelet count is low, and he is transfusion-dependent.
3. Acute kidney injury (ARF): The patient's creatinine levels are slightly elevated, and he is at risk for further kidney damage due to his immunosuppressive medications and dehydration.
4. Rising liver enzymes: The patient's liver enzymes are elevated, and he is at risk for liver damage due to his immunosuppressive medications and GVHD.
5. CMV viremia: The patient's CMV viral load is negative, but he is at risk for CMV reactivation due to his immunosuppressive medications.
6. Gastrointestinal symptoms: The patient is experiencing diarrhea, nausea, and vomiting, which may be related to his immunosuppressive medications and GVHD.
7. Hyperglycemia: The patient is experiencing hyperglycemia due to his immunosuppressive medications and steroids.

The patient is currently receiving treatment for his complications, including:

1. Blood transfusions: The patient is receiving blood transfusions to increase his hemoglobin and hematocrit levels.
2. Immunosuppressive medications: The patient is receiving immunosuppressive medications to prevent rejection of his transplant and to manage his GVHD.
3. Antiviral medications: The patient is receiving antiviral medications to prevent CMV reactivation.
4. Antibiotics: The patient is receiving antibiotics to treat his gastrointestinal symptoms and to prevent infection.
5. Insulin: The patient is receiving insulin to manage his hyperglycemia.

The patient is currently in the ICU and is being closely monitored for any changes in his condition. His code status is full code, and he is receiving prophylactic treatment for DVT and stress ulcers."
116756.0,286913,2167-04-24 11:21:00,Physician ,Physician Attending Progress Note,"Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   Hct increased today, s/p 2 units PRBC overnight
   CT [**Last Name (un) 499**] repeated, increase in size of hematoma with increased
   peri-splenic blood
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-23**] 09:09 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2167-4-24**] 11:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37
C (98.6
   HR: 80 (78 - 120) bpm
   BP: 163/95(110) {109/70(86) - 177/100(151)} mmHg
   RR: 16 (13 - 28) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  4,272 mL
                                                                  1,586 mL
   PO:
                                                                    100 mL
           TF:
   IVF:
                                                                  1,423 mL
                                                                    109 mL
   Blood products:
                                                                  1,510 mL
                                                                    549 mL
   Total out:
                                                                  1,650 mL
                                                                  1,955 mL
   Urine:
                                                                  1,650 mL
                                                                  1,955 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,622 mL
                                                                   -369 mL
   Respiratory support
   SpO2: 99%
   ABG: ///26/
   Physical Examination
   General Appearance: jaundiced
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Bowel sounds present, distended, no guarding, no
   ecchymoses on back
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm
   Neurologic: Attentive, Responds to: Not assessed, Movement: Not
   assessed, Tone: Not assessed
   Labs / Radiology
   10.3 g/dL
   58 K/uL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   27.4 %
   4.4 K/uL
        [image002.jpg]
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   Plt
   57
   46
   130
   107
   86
   58
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   Assessment and Plan
   54 yr old s/p cord blood transplant d 99, course complicated by CMV
   viremia and now GVHD.
   S/p transjugular biopsy complicated by acute bleed.
   1. Acute bleeding - in setting of transjugular bx with refractory
   thrombocytopenia. Will need to keep platelets > 50 until Hct
   stabilizes.
   Check hct [**5-10**] h for now. Aim for Hct ~23. Finally seems to be
   stabilizing.
   2. GVHD - on steroids, on cellcept, cyclo. On caspo for hx of fungal
   infection
   3. Thrombocytopenia - multifactorial, keep > 50K
   4. CMV viremia - most recent viral load negative on [**4-21**], on acyclovir
   5. ARF - making urine, not currently on dialysis, lytes ok
   6. HTN - stable, on norvasc, labetolol
   7. ID issues - low grade temps, no evidence of pneumonia. D/c levoflox.
   F/u cultures, so far negative.
   8. Pain control
 will start longer acting PO morphine
   Addendum:
   Am repeat labs show hct 29, platelet 52.
   ICU Care
   Nutrition:
   TPN w/ Lipids - [**2167-4-24**] 06:34 AM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Tunneled (Hickman) Line - [**2167-4-23**] 01:22 PM
   Prophylaxis:
   DVT: boots
   Stress ulcer: PPI
   Communication:
   Code status: Full code
   Disposition :ICU
   Total time spent: 32 minutes, critical care time
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   Hct increased today, s/p 2 units PRBC overnight
   CT [**Last Name (un) 499**] repeated, increase in size of hematoma with increased
   peri-splenic blood
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-23**] 09:09 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2167-4-24**] 11:19 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37
C (98.6
   HR: 80 (78 - 120) bpm
   BP: 163/95(110) {109/70(86) - 177/100(151)} mmHg
   RR: 16 (13 - 28) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  4,272 mL
                                                                  1,586 mL
   PO:
                                                                    100 mL
           TF:
   IVF:
                                                                  1,423 mL
                                                                    109 mL
   Blood products:
                                                                  1,510 mL
                                                                    549 mL
   Total out:
                                                                  1,650 mL
                                                                  1,955 mL
   Urine:
                                                                  1,650 mL
                                                                  1,955 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,622 mL
                                                                   -369 mL
   Respiratory support
   SpO2: 99%
   ABG: ///26/
   Physical Examination
   General Appearance: jaundiced
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
   Abdominal: Soft, Bowel sounds present, distended, no guarding, no
   ecchymoses on back
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm
   Neurologic: Attentive, Responds to: Not assessed, Movement: Not
   assessed, Tone: Not assessed
   Labs / Radiology
   10.3 g/dL
   58 K/uL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   27.4 %
   4.4 K/uL
        [image002.jpg]
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   Plt
   57
   46
   130
   107
   86
   58
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   Assessment and Plan
   54 yr old s/p cord blood transplant d 99, course complicated by CMV
   viremia and now GVHD.
   S/p transjugular biopsy complicated by acute bleed.
   1. Acute bleeding - in setting of transjugular bx with refractory
   thrombocytopenia. Will need to keep platelets > 50 until Hct
   stabilizes.
   Check hct [**5-10**] h for now. Aim for Hct ~23. Finally seems to be
   stabilizing.
   2. GVHD - on steroids, on cellcept, cyclo. On caspo for hx of fungal
   infection
   3. Thrombocytopenia - multifactorial, keep > 50K
   4. CMV viremia - most recent viral load negative on [**4-21**], on acyclovir
   5. ARF - making urine, not currently on dialysis, lytes ok
   6. HTN - stable, on norvasc, labetolol
   7. ID issues - low grade temps, no evidence of pneumonia. D/c levoflox.
   F/u cultures, so far negative.
   8. Pain control
 will start longer acting PO morphine
   Addendum:
   Am repeat labs show hct 29, platelet 52.
   ICU Care
   Nutrition:
   TPN w/ Lipids - [**2167-4-24**] 06:34 AM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Tunneled (Hickman) Line - [**2167-4-23**] 01:22 PM
   Prophylaxis:
   DVT: boots
   Stress ulcer: PPI
   Communication:
   Code status: Full code
   Disposition :ICU
   Total time spent: 32 minutes, critical care time<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 54-year-old male who underwent a cord blood transplant 99 days ago and is currently in the ICU due to complications. He has developed CMV viremia and GVHD, and had a transjugular biopsy that was complicated by an acute bleed. The patient has thrombocytopenia, and his platelet count is currently 52. He has also developed ARF and is making urine, but is not on dialysis. His blood pressure is stable, and he is on medication for hypertension. The patient has low-grade temperatures, but no evidence of pneumonia. He is being treated with caspofungin for a history of fungal infection.

Potential medical complications:

1. Hemorrhage: The patient's thrombocytopenia and acute bleed during the transjugular biopsy increase the risk of further bleeding.
2. GVHD: The patient's GVHD is being treated with steroids, cellcept, and cyclo, but the risk of complications such as liver dysfunction, skin rash, and gastrointestinal symptoms remains.
3. Thrombocytopenia: The patient's platelet count is currently 52, which is still below the normal range. The risk of bleeding remains high, and the patient will need to be monitored closely.
4. CMV viremia: The patient's CMV viremia is being treated with acyclovir, but the risk of complications such as pneumonia, esophagitis, and colitis remains.
5. ARF: The patient's ARF is being monitored, and the risk of complications such as electrolyte imbalances, acidosis, and uremic syndrome remains.
6. Hypertension: The patient's hypertension is being treated with medication, but the risk of complications such as cardiac arrhythmias, heart failure, and stroke remains.
7. ID issues: The patient's low-grade temperatures and lack of evidence of pneumonia suggest that he may have a low-grade infection, which could lead to complications such as sepsis and organ failure.
8. Pain control: The patient is at risk for inadequate pain control, which could lead to discomfort, anxiety, and depression."
116756.0,286913,2167-04-25 06:36:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - STOP [**2167-4-24**] 01:22 PM
 TUNNELED (HICKMAN) LINE - START [**2167-4-24**] 08:54 PM
   - holding acyclovir for now per BMT for bump in creatinine
   - Hct trended down overnight from 29 to 25, getting 1upRBCs now
   - rec'd two bags plts
   - restarted home regimen Ms Contin
   - Liver biopsy final report + GVHD
   - BP poorly controlled, gave IV hydralazine
   - CMV viremia reported from lab this am
   - BS low, received
 amp D50
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-24**] 08:00 PM
   Infusions:
   Other ICU medications:
   Carafate (Sucralfate) - [**2167-4-24**] 08:00 PM
   Other medications:
   Flowsheet Data as of  [**2167-4-25**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 89 (74 - 89) bpm
   BP: 171/115(126) {91/63(70) - 191/153(158)} mmHg
   RR: 28 (9 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  5,070 mL
                                                                  1,199 mL
   PO:
                                                                  1,280 mL
                                                                    350 mL
   TF:
   IVF:
                                                                    618 mL
                                                                     61 mL
   Blood products:
                                                                  1,142 mL
                                                                    277 mL
   Total out:
                                                                  3,455 mL
                                                                  1,520 mL
   Urine:
                                                                  3,455 mL
                                                                  1,520 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,615 mL
                                                                   -321 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Labs / Radiology
   93 K/uL
   10.9 g/dL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   25.4 %
   4.5 K/uL
        [image002.jpg]
   Repeat Am labs s/p 1upRBCs
   WBC 4.1, Hct 27.5, Plts 54                      Na 138, K 5.5, Cl 102,
   Cl 28, BUN 70, Creatinine 2.1
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
                             [**2167-4-24**]  08:44 AM
                             [**2167-4-24**]  03:40 PM
                             [**2167-4-24**]  07:27 PM
                             [**2167-4-25**]  12:01 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   5.2
   4.5
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   29.4
   29.7
   27.9
   25.4
   Plt
   57
   46
   130
   107
   86
   58
   52
   39
   63
   93
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: [**2167-4-22**] 4:30 pm TISSUE     Site:
   LIVER      Source: Liver r/o CMV.
      GRAM STAIN (Final [**2167-4-22**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      TISSUE (Preliminary):    NO GROWTH.
      ANAEROBIC CULTURE (Preliminary):    NO GROWTH.
      FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED.
      VIRAL CULTURE (Preliminary):    No Virus isolated so far.
      CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) (Pending):
   Microbiology: CVM VL pending from [**4-23**]
   [**4-22**] liver biopsy:
   Liver, transjugular needle biopsy:
   1.  Mild portal, predominantly mononuclear inflammation with
   lymphocytic bile duct infiltration, associated bile duct damage and
   focal endothelialitis, see note.
   2.  Marked iron deposition in Kupffer cells and mild to moderate iron
   within hepatocytes on special stain; focal associated hepatocyte
   necrosis seen.
   3.  Scattered apoptotic hepatocytes with minimal lobular inflammation;
   no significant steatosis present.
   4.  GMS stain is negative for fungi, with a satisfactory control.
   5.  CMV immunostain is negative for viral inclusions, with a
   satisfactory control.
   6.  Trichrome stain demonstrates minimal portal fibrosis.
   Note:  The biliary features are consistent with acute graft vs. host
   disease. A component of injury related to hemachromatosis is also
   identified
   Assessment and Plan
   54 y.o. M with hx of recurrent multiple myeloma now Day 100 s/p cord
   blood transplant course c/b CMV viremia, ARF, low level hemolysis &
   GVHD in liver & colon
   .
   # s/p transjugular biopsy c/b bleed: pt transferred with HCT drop, CT
   abd showed increasing perihepatic hematoma, hct stable through day but
   trended down in evening from 29 to 25. Receiving 1upRBCs now, plts
   transfused up to 93.
   - f/u post transfusion hct, transfusion goal 27-30
   - serial plts, goal transfusion plt ct>50-75
   - serial abd exams
   - surgery & IR aware (page [**Numeric Identifier 1727**] , Dr. [**Last Name (STitle) 1728**] if needed) no plan for
   acute intervention
   - starting Ms Contin 15mg [**Hospital1 **] with breakthrough morphine prn
   # Multiple myeloma Day 100 s/p Cord Tranplant: recent bone marrow day
   +79 <10% celllular, marked hypoplastic megakaryocytes. Chimerism:
   mostly donor so shouldn't be hemolysing.
   - monitor cell counts - still transfusion dependent (goal plts >50 &
   goal hct >27-30)
   - continue cellcept & methylpred
   - continue cyclosporin [**Month (only) 38**] to 150mg [**Hospital1 **]
   - f/u am cyclopsporin level & adjust prn for approx 200
   .
   # BRBPR/Diarrhea: recent EGD with e/o gastritis/duodenitis, path neg
   for CMV/GVHD. H. pylori Ab+, capsule showed persistent bleeding in SB,
   no intervention at this time per GI.  Pt with persistent diarrhea
   despite increased immunosuppression for presumed GVH.  Currently on TPN
   & clears for bowel rest
   - current regimen of solu-medrol 40mg [**Hospital1 **], cellcept 750mg IV BID,
   cyclosporin 150mg [**Hospital1 **]
   - continue sucralfate, pantoprazole
   - transfusion scales: keep hct>30 and platelets>30
   #Abn LFTs
 most likely etiology GVHD given [**4-22**] liver biopsy positive,
   all viral studies negative ( CMV, HBV, HCV)
   - trend LFTs daily
   - immune suppression per BMT
   # ARF: Cr trending up with hyperkalemia at 5.5.  Etiology unclear,
   possibly [**3-7**] tacrolimus, cyclosporin, foscarnet, dehydration [**3-7**]
   chronic diarrhea  & drop in hct vs renal GVHD.  Acyclovir held per BMT
   due to concern for renal toxicity
   -repeat K & treat if persistently elevated
   -UPEP, SPEP negative.
   -monitor Creatinine, consider urine lytes if trending up
   .
   # CMV Viremia: repeat CMV VL have been negative through [**Month (only) **]/[**Month (only) **], but
   was initally treated with valgancyclovir, then switched to foscarnet
   [**3-7**] renal failure and now recently on acyclovir. Per BMT, holding
   Acyclovir for a few days given slight rise in creatinine, will restart
   on [**4-27**]. ID recommended continuing Acyclovir 400 [**Hospital1 **] for CMV ppx at
   least 1 year
   - CMV VL q5 days - all recent VL negative
   .
   # HTN: slightly hypertensive, gave one time dose of hydralazine & sbp
   dropped to 100s
   - continue Amlodipine 10mg &  Labetalol 400 mg TID
   .
   # Diabetes: Hyperglycemic with steroids
   - Continue ISS and insulin in TPN
   ICU Care
   Nutrition: TPN w/ Lipids - [**2167-4-24**] 06:25 PM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Tunneled (Hickman) Line - [**2167-4-24**] 08:54 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - STOP [**2167-4-24**] 01:22 PM
 TUNNELED (HICKMAN) LINE - START [**2167-4-24**] 08:54 PM
   - holding acyclovir for now per BMT for bump in creatinine
   - Hct trended down overnight from 29 to 25, getting 1upRBCs now
   - rec'd two bags plts
   - restarted home regimen Ms Contin
   - Liver biopsy final report + GVHD
   - BP poorly controlled, gave IV hydralazine
   - CMV viremia reported from lab this am
   - BS low, received
 amp D50
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-24**] 08:00 PM
   Infusions:
   Other ICU medications:
   Carafate (Sucralfate) - [**2167-4-24**] 08:00 PM
   Other medications:
   Flowsheet Data as of  [**2167-4-25**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 89 (74 - 89) bpm
   BP: 171/115(126) {91/63(70) - 191/153(158)} mmHg
   RR: 28 (9 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  5,070 mL
                                                                  1,199 mL
   PO:
                                                                  1,280 mL
                                                                    350 mL
   TF:
   IVF:
                                                                    618 mL
                                                                     61 mL
   Blood products:
                                                                  1,142 mL
                                                                    277 mL
   Total out:
                                                                  3,455 mL
                                                                  1,520 mL
   Urine:
                                                                  3,455 mL
                                                                  1,520 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,615 mL
                                                                   -321 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Labs / Radiology
   93 K/uL
   10.9 g/dL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   25.4 %
   4.5 K/uL
        [image002.jpg]
   Repeat Am labs s/p 1upRBCs
   WBC 4.1, Hct 27.5, Plts 54                      Na 138, K 5.5, Cl 102,
   Cl 28, BUN 70, Creatinine 2.1
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
                             [**2167-4-24**]  08:44 AM
                             [**2167-4-24**]  03:40 PM
                             [**2167-4-24**]  07:27 PM
                             [**2167-4-25**]  12:01 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   5.2
   4.5
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   29.4
   29.7
   27.9
   25.4
   Plt
   57
   46
   130
   107
   86
   58
   52
   39
   63
   93
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: [**2167-4-22**] 4:30 pm TISSUE     Site:
   LIVER      Source: Liver r/o CMV.
      GRAM STAIN (Final [**2167-4-22**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      TISSUE (Preliminary):    NO GROWTH.
      ANAEROBIC CULTURE (Preliminary):    NO GROWTH.
      FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED.
      VIRAL CULTURE (Preliminary):    No Virus isolated so far.
      CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) (Pending):
   Microbiology: CVM VL pending from [**4-23**]
   [**4-22**] liver biopsy:
   Liver, transjugular needle biopsy:
   1.  Mild portal, predominantly mononuclear inflammation with
   lymphocytic bile duct infiltration, associated bile duct damage and
   focal endothelialitis, see note.
   2.  Marked iron deposition in Kupffer cells and mild to moderate iron
   within hepatocytes on special stain; focal associated hepatocyte
   necrosis seen.
   3.  Scattered apoptotic hepatocytes with minimal lobular inflammation;
   no significant steatosis present.
   4.  GMS stain is negative for fungi, with a satisfactory control.
   5.  CMV immunostain is negative for viral inclusions, with a
   satisfactory control.
   6.  Trichrome stain demonstrates minimal portal fibrosis.
   Note:  The biliary features are consistent with acute graft vs. host
   disease. A component of injury related to hemachromatosis is also
   identified
   Assessment and Plan
   54 y.o. M with hx of recurrent multiple myeloma now Day 100 s/p cord
   blood transplant course c/b CMV viremia, ARF, low level hemolysis &
   GVHD in liver & colon
   .
   # s/p transjugular biopsy c/b bleed: pt transferred with HCT drop, CT
   abd showed increasing perihepatic hematoma, hct stable through day but
   trended down in evening from 29 to 25. Receiving 1upRBCs now, plts
   transfused up to 93.
   - f/u post transfusion hct, transfusion goal 27-30
   - serial plts, goal transfusion plt ct>50-75
   - serial abd exams
   - surgery & IR aware (page [**Numeric Identifier 1727**] , Dr. [**Last Name (STitle) 1728**] if needed) no plan for
   acute intervention
   - starting Ms Contin 15mg [**Hospital1 **] with breakthrough morphine prn
   # Multiple myeloma Day 100 s/p Cord Tranplant: recent bone marrow day
   +79 <10% celllular, marked hypoplastic megakaryocytes. Chimerism:
   mostly donor so shouldn't be hemolysing.
   - monitor cell counts - still transfusion dependent (goal plts >50 &
   goal hct >27-30)
   - continue cellcept & methylpred
   - continue cyclosporin [**Month (only) 38**] to 150mg [**Hospital1 **]
   - f/u am cyclopsporin level & adjust prn for approx 200
   .
   # BRBPR/Diarrhea: recent EGD with e/o gastritis/duodenitis, path neg
   for CMV/GVHD. H. pylori Ab+, capsule showed persistent bleeding in SB,
   no intervention at this time per GI.  Pt with persistent diarrhea
   despite increased immunosuppression for presumed GVH.  Currently on TPN
   & clears for bowel rest
   - current regimen of solu-medrol 40mg [**Hospital1 **], cellcept 750mg IV BID,
   cyclosporin 150mg [**Hospital1 **]
   - continue sucralfate, pantoprazole
   - transfusion scales: keep hct>30 and platelets>30
   #Abn LFTs
 most likely etiology GVHD given [**4-22**] liver biopsy positive,
   all viral studies negative ( CMV, HBV, HCV)
   - trend LFTs daily
   - immune suppression per BMT
   # ARF: Cr trending up with hyperkalemia at 5.5.  Etiology unclear,
   possibly [**3-7**] tacrolimus, cyclosporin, foscarnet, dehydration [**3-7**]
   chronic diarrhea  & drop in hct vs renal GVHD.  Acyclovir held per BMT
   due to concern for renal toxicity
   -repeat K & treat if persistently elevated
   -UPEP, SPEP negative.
   -monitor Creatinine, consider urine lytes if trending up
   .
   # CMV Viremia: repeat CMV VL have been negative through [**Month (only) **]/[**Month (only) **], but
   was initally treated with valgancyclovir, then switched to foscarnet
   [**3-7**] renal failure and now recently on acyclovir. Per BMT, holding
   Acyclovir for a few days given slight rise in creatinine, will restart
   on [**4-27**]. ID recommended continuing Acyclovir 400 [**Hospital1 **] for CMV ppx at
   least 1 year
   - CMV VL q5 days - all recent VL negative
   .
   # HTN: slightly hypertensive, gave one time dose of hydralazine & sbp
   dropped to 100s
   - continue Amlodipine 10mg &  Labetalol 400 mg TID
   .
   # Diabetes: Hyperglycemic with steroids
   - Continue ISS and insulin in TPN
   ICU Care
   Nutrition: TPN w/ Lipids - [**2167-4-24**] 06:25 PM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Tunneled (Hickman) Line - [**2167-4-24**] 08:54 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 54-year-old male with a history of recurrent multiple myeloma who underwent cord blood transplant 100 days ago. He is currently in the ICU with multiple complications, including:

* CMV viremia
* Acute graft-vs-host disease (GVHD) in the liver and colon
* Renal failure with hyperkalemia
* Low-level hemolysis
* Hypertension
* Diabetes
* Abnormal liver function tests (LFTs)

The patient's condition has been unstable, with a trend of decreasing hemoglobin and platelet counts, and increasing creatinine levels. He has been treated with various medications, including immunosuppressants, antibiotics, and antiviral agents.

Potential Medical Complications:

1. Progressive renal failure: The patient's creatinine levels are trending upward, and he is at risk of developing acute kidney injury or chronic kidney disease.
2. Sepsis: The patient's liver biopsy revealed mild portal inflammation and lymphocytic bile duct infiltration, which may be indicative of a septic process.
3. Gastrointestinal bleeding: The patient has a history of gastritis and duodenitis, and he is at risk of developing gastrointestinal bleeding, particularly in the setting of anticoagulation therapy.
4. Respiratory failure: The patient's oxygen saturation levels are stable, but he may be at risk of developing respiratory failure, particularly if his lung function deteriorates further.
5. Infection: The patient is at risk of developing infections, particularly in the setting of immunosuppression and invasive lines.
6. Cardiovascular complications: The patient's hypertension is poorly controlled, and he may be at risk of developing cardiovascular complications, such as cardiac arrhythmias or myocardial infarction.
7. Neurological complications: The patient's liver dysfunction may lead to neurological complications, such as encephalopathy or seizures.

Plan:

1. Continue immunosuppressive therapy to prevent GVHD and rejection.
2. Monitor the patient's renal function closely and adjust his fluid and electrolyte management accordingly.
3. Treat the patient's hypertension and hyperglycemia with medications and lifestyle modifications.
4. Monitor the patient's liver function tests and adjust his medication regimen as necessary.
5. Consider serial imaging studies to monitor the patient's liver and colon for signs of GVHD or other complications.
6. Monitor the patient's respiratory status closely and consider mechanical ventilation if necessary.
7. Consider antibiotics and antiviral agents if the patient develops signs of sepsis or infection.
8. Monitor the patient's neurological status closely and consider anticonvulsant therapy if necessary."
116756.0,286913,2167-04-25 06:36:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - holding acyclovir for now per BMT for bump in creatinine
   - Hct trended down overnight from 29 to 25, getting 1upRBCs now
   - s/p transfusion with 2u plts
   - restarted home regimen Ms Contin
   - Liver biopsy final report + GVHD
   - CMV VL + for >800 copies
   - BS low, received
 amp D50
   Pt doing okay, abd pain currently [**4-13**].  Denies CP/SOB
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-24**] 08:00 PM
   Infusions:
   Other ICU medications:
   Carafate (Sucralfate) - [**2167-4-24**] 08:00 PM
   Other medications:
   Flowsheet Data as of  [**2167-4-25**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 89 (74 - 89) bpm
   BP: 171/115(126) {91/63(70) - 191/153(158)} mmHg
   RR: 28 (9 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  5,070 mL
                                                                  1,199 mL
   PO:
                                                                  1,280 mL
                                                                    350 mL
   TF:
   IVF:
                                                                    618 mL
                                                                     61 mL
   Blood products:
                                                                  1,142 mL
                                                                    277 mL
   Total out:
                                                                  3,455 mL
                                                                  1,520 mL
   Urine:
                                                                  3,455 mL
                                                                  1,520 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,615 mL
                                                                   -321 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   GEN: NAD, tremulous & appears mildly uncomfortable
   HEENT: diffuse darkened skin lesions, mild scleral icterus
   CV: RRR no m/r/g
   RESP: CTAB no w/r
   ABD: mildly distended & TTP over RUQ, no ecchymosis, NABS
   EXTR: no c/c/e (tremors)
   Labs / Radiology
   93 K/uL
   10.9 g/dL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   25.4 %
   4.5 K/uL
        [image002.jpg] LFTs
   Repeat Am labs s/p 1upRBCs
   WBC 4.1, Hct 27.5, Plts 54                      Na 138, K 5.5, Cl 102,
   Cl 28, BUN 70, Creatinine 2.1
   AST 115, ALT 158, AP 134, T Bili 6.2
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
                             [**2167-4-24**]  08:44 AM
                             [**2167-4-24**]  03:40 PM
                             [**2167-4-24**]  07:27 PM
                             [**2167-4-25**]  12:01 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   5.2
   4.5
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   29.4
   29.7
   27.9
   25.4
   Plt
   57
   46
   130
   107
   86
   58
   52
   39
   63
   93
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: [**2167-4-22**] 4:30 pm TISSUE     Site:
   LIVER      Source: Liver r/o CMV.
      GRAM STAIN (Final [**2167-4-22**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      TISSUE (Preliminary):    NO GROWTH.
      ANAEROBIC CULTURE (Preliminary):    NO GROWTH.
      FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED.
      VIRAL CULTURE (Preliminary):    No Virus isolated so far.
      CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) (Pending):
   Microbiology: CVM VL + for > 800copies today
   [**4-22**] Liver, transjugular needle biopsy:
   1.  Mild portal, predominantly mononuclear inflammation with
   lymphocytic bile duct infiltration, associated bile duct damage and
   focal endothelialitis, see note.
   2.  Marked iron deposition in Kupffer cells and mild to moderate iron
   within hepatocytes on special stain; focal associated hepatocyte
   necrosis seen.
   3.  Scattered apoptotic hepatocytes with minimal lobular inflammation;
   no significant steatosis present.
   4.  GMS stain is negative for fungi, with a satisfactory control.
   5.  CMV immunostain is negative for viral inclusions, with a
   satisfactory control.
   6.  Trichrome stain demonstrates minimal portal fibrosis.
   Note:  The biliary features are consistent with acute graft vs. host
   disease. A component of injury related to hemachromatosis is also
   identified
   Assessment and Plan
   54 y.o. M with hx of recurrent multiple myeloma now Day 100 s/p cord
   blood transplant course c/b CMV viremia, ARF, low level hemolysis &
   GVHD in liver & colon
   .
   # s/p transjugular biopsy c/b bleed: Pt transferred to  [**Hospital Unit Name 44**] with HCT
   drop, CT abd showed increasing perihepatic hematoma, hct stable through
   day but trended down in evening from 29 to 25. Receiving 1upRBCs now,
   plts transfused up to 93.
   - f/u post transfusion hct, transfusion goal 27-30
   - f/u pm plts, goal transfusion plt ct>50
   - serial abd exams
   - surgery & IR aware (page [**Numeric Identifier 1727**] , Dr. [**Last Name (STitle) 1728**] if needed) no plan for
   acute intervention
   - starting Ms Contin 15mg [**Hospital1 **] with breakthrough morphine prn
   # Multiple myeloma Day 100 s/p Cord Tranplant: recent bone marrow day
   +79 <10% celllular, markedly hypoplastic megakaryocytes. Chimerism:
   mostly donor so shouldn't be hemolysing.
   - monitor cell counts - still transfusion dependent (goal plts >50 &
   goal hct >27-30)
   - continue cellcept & methylprednislone per BMT
   - continue cyclosporin [**Month (only) 38**] to 150mg [**Hospital1 **]
   - f/u am cyclopsporin level & adjust prn for goal level 200
   .
   # CMV Viremia: CMV VL had been neg through [**Month (only) **]/[**Month (only) **]. Pt had been prev
   positive & treated with valgancyclovir, switched to foscarnet & most
   recently on acyclovir.  ID recommended continuing Acyclovir 400 [**Hospital1 **] for
   CMV ppx at least 1 year.  CMV Viral Load now positive with >800 copies
   likely due to increased immunosuppression
   - will give one dose of Acyclovir 400mg now & f/u BMT regarding plan
   for treatment of CMV viremia
   .
   #Abn LFTs
 most likely etiology GVHD given [**4-22**] liver biopsy positive,
   however, pt now has CMV viremia recurrence, may be contributing to abn
   LFTs.  Tbili up from 5 to 6.1 today, likely due to increased
   hemolysis.
   - trend LFTs daily
   - t/b with BMT regarding CMV treatment & immune suppression
   # ARF: Baseline creatinine 1.8, now trending up at 2.1 with transient
   hyperkalemia of 5.5, repeat K down at 4.1.  Etiology unclear, possibly
   cyclosporine induced [**Month (only) 38**] GFR , foscarnet, dehydration [**3-7**] chronic
   diarrhea  & drop in hct vs renal GVHD.  Acyclovir was held o/n per BMT
   due to concern for renal toxicity. Pt continues to have good UOP.
   -follow up pm lytes & send urine lytes if creatinine continues to rise
   -UPEP, SPEP negative
   # BRBPR/Diarrhea: recent EGD with e/o gastritis/duodenitis, path neg
   for CMV/GVHD. H. pylori Ab+, capsule showed persistent bleeding in SB,
   no intervention planned per GI.  Pt with persistent diarrhea despite
   increased immunosuppression for presumed GVH.  Currently on TPN &
   clears for bowel rest
   - current regimen of solu-medrol 40mg [**Hospital1 **], cellcept 750mg IV BID,
   cyclosporin 150mg [**Hospital1 **]
   - continue sucralfate, pantoprazole
   - transfusion scales: keep hct>27 and platelets>50
   .
   # HTN: continues to be mildly hypertensive, gave one time dose of
   hydralazine & sbp dropped to 100s
   - continue Amlodipine 10mg &  Labetalol 400 mg TID
   .
   # Diabetes: BS have been running  low despite steroids & TPN, will [**Month (only) 38**]
   insulin in TPN, this may be partly due to liver dysfunctn
   - Continue ISS, Dextrose prn & decrease insulin in TPN
   ICU Care
   Nutrition: TPN w/ Lipids - [**2167-4-24**] 06:25 PM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines: Tunneled (Hickman) Line - [**2167-4-24**] 08:54 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - holding acyclovir for now per BMT for bump in creatinine
   - Hct trended down overnight from 29 to 25, getting 1upRBCs now
   - s/p transfusion with 2u plts
   - restarted home regimen Ms Contin
   - Liver biopsy final report + GVHD
   - CMV VL + for >800 copies
   - BS low, received
 amp D50
   Pt doing okay, abd pain currently [**4-13**].  Denies CP/SOB
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-24**] 08:00 PM
   Infusions:
   Other ICU medications:
   Carafate (Sucralfate) - [**2167-4-24**] 08:00 PM
   Other medications:
   Flowsheet Data as of  [**2167-4-25**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 89 (74 - 89) bpm
   BP: 171/115(126) {91/63(70) - 191/153(158)} mmHg
   RR: 28 (9 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  5,070 mL
                                                                  1,199 mL
   PO:
                                                                  1,280 mL
                                                                    350 mL
   TF:
   IVF:
                                                                    618 mL
                                                                     61 mL
   Blood products:
                                                                  1,142 mL
                                                                    277 mL
   Total out:
                                                                  3,455 mL
                                                                  1,520 mL
   Urine:
                                                                  3,455 mL
                                                                  1,520 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,615 mL
                                                                   -321 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   GEN: NAD, tremulous & appears mildly uncomfortable
   HEENT: diffuse darkened skin lesions, mild scleral icterus
   CV: RRR no m/r/g
   RESP: CTAB no w/r
   ABD: mildly distended & TTP over RUQ, no ecchymosis, NABS
   EXTR: no c/c/e (tremors)
   Labs / Radiology
   93 K/uL
   10.9 g/dL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   25.4 %
   4.5 K/uL
        [image002.jpg] LFTs
   Repeat Am labs s/p 1upRBCs
   WBC 4.1, Hct 27.5, Plts 54                      Na 138, K 5.5, Cl 102,
   Cl 28, BUN 70, Creatinine 2.1
   AST 115, ALT 158, AP 134, T Bili 6.2
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
                             [**2167-4-24**]  08:44 AM
                             [**2167-4-24**]  03:40 PM
                             [**2167-4-24**]  07:27 PM
                             [**2167-4-25**]  12:01 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   5.2
   4.5
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   29.4
   29.7
   27.9
   25.4
   Plt
   57
   46
   130
   107
   86
   58
   52
   39
   63
   93
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: [**2167-4-22**] 4:30 pm TISSUE     Site:
   LIVER      Source: Liver r/o CMV.
      GRAM STAIN (Final [**2167-4-22**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      TISSUE (Preliminary):    NO GROWTH.
      ANAEROBIC CULTURE (Preliminary):    NO GROWTH.
      FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED.
      VIRAL CULTURE (Preliminary):    No Virus isolated so far.
      CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) (Pending):
   Microbiology: CVM VL + for > 800copies today
   [**4-22**] Liver, transjugular needle biopsy:
   1.  Mild portal, predominantly mononuclear inflammation with
   lymphocytic bile duct infiltration, associated bile duct damage and
   focal endothelialitis, see note.
   2.  Marked iron deposition in Kupffer cells and mild to moderate iron
   within hepatocytes on special stain; focal associated hepatocyte
   necrosis seen.
   3.  Scattered apoptotic hepatocytes with minimal lobular inflammation;
   no significant steatosis present.
   4.  GMS stain is negative for fungi, with a satisfactory control.
   5.  CMV immunostain is negative for viral inclusions, with a
   satisfactory control.
   6.  Trichrome stain demonstrates minimal portal fibrosis.
   Note:  The biliary features are consistent with acute graft vs. host
   disease. A component of injury related to hemachromatosis is also
   identified
   Assessment and Plan
   54 y.o. M with hx of recurrent multiple myeloma now Day 100 s/p cord
   blood transplant course c/b CMV viremia, ARF, low level hemolysis &
   GVHD in liver & colon
   .
   # s/p transjugular biopsy c/b bleed: Pt transferred to  [**Hospital Unit Name 44**] with HCT
   drop, CT abd showed increasing perihepatic hematoma, hct stable through
   day but trended down in evening from 29 to 25. Receiving 1upRBCs now,
   plts transfused up to 93.
   - f/u post transfusion hct, transfusion goal 27-30
   - f/u pm plts, goal transfusion plt ct>50
   - serial abd exams
   - surgery & IR aware (page [**Numeric Identifier 1727**] , Dr. [**Last Name (STitle) 1728**] if needed) no plan for
   acute intervention
   - starting Ms Contin 15mg [**Hospital1 **] with breakthrough morphine prn
   # Multiple myeloma Day 100 s/p Cord Tranplant: recent bone marrow day
   +79 <10% celllular, markedly hypoplastic megakaryocytes. Chimerism:
   mostly donor so shouldn't be hemolysing.
   - monitor cell counts - still transfusion dependent (goal plts >50 &
   goal hct >27-30)
   - continue cellcept & methylprednislone per BMT
   - continue cyclosporin [**Month (only) 38**] to 150mg [**Hospital1 **]
   - f/u am cyclopsporin level & adjust prn for goal level 200
   .
   # CMV Viremia: CMV VL had been neg through [**Month (only) **]/[**Month (only) **]. Pt had been prev
   positive & treated with valgancyclovir, switched to foscarnet & most
   recently on acyclovir.  ID recommended continuing Acyclovir 400 [**Hospital1 **] for
   CMV ppx at least 1 year.  CMV Viral Load now positive with >800 copies
   likely due to increased immunosuppression
   - will give one dose of Acyclovir 400mg now & f/u BMT regarding plan
   for treatment of CMV viremia
   .
   #Abn LFTs
 most likely etiology GVHD given [**4-22**] liver biopsy positive,
   however, pt now has CMV viremia recurrence, may be contributing to abn
   LFTs.  Tbili up from 5 to 6.1 today, likely due to increased
   hemolysis.
   - trend LFTs daily
   - t/b with BMT regarding CMV treatment & immune suppression
   # ARF: Baseline creatinine 1.8, now trending up at 2.1 with transient
   hyperkalemia of 5.5, repeat K down at 4.1.  Etiology unclear, possibly
   cyclosporine induced [**Month (only) 38**] GFR , foscarnet, dehydration [**3-7**] chronic
   diarrhea  & drop in hct vs renal GVHD.  Acyclovir was held o/n per BMT
   due to concern for renal toxicity. Pt continues to have good UOP.
   -follow up pm lytes & send urine lytes if creatinine continues to rise
   -UPEP, SPEP negative
   # BRBPR/Diarrhea: recent EGD with e/o gastritis/duodenitis, path neg
   for CMV/GVHD. H. pylori Ab+, capsule showed persistent bleeding in SB,
   no intervention planned per GI.  Pt with persistent diarrhea despite
   increased immunosuppression for presumed GVH.  Currently on TPN &
   clears for bowel rest
   - current regimen of solu-medrol 40mg [**Hospital1 **], cellcept 750mg IV BID,
   cyclosporin 150mg [**Hospital1 **]
   - continue sucralfate, pantoprazole
   - transfusion scales: keep hct>27 and platelets>50
   .
   # HTN: continues to be mildly hypertensive, gave one time dose of
   hydralazine & sbp dropped to 100s
   - continue Amlodipine 10mg &  Labetalol 400 mg TID
   .
   # Diabetes: BS have been running  low despite steroids & TPN, will [**Month (only) 38**]
   insulin in TPN, this may be partly due to liver dysfunctn
   - Continue ISS, Dextrose prn & decrease insulin in TPN
   ICU Care
   Nutrition: TPN w/ Lipids - [**2167-4-24**] 06:25 PM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines: Tunneled (Hickman) Line - [**2167-4-24**] 08:54 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following potential medical complications can arise:

1. **Graft-versus-host disease (GVHD)**: The patient has been diagnosed with GVHD in the liver and colon, which can lead to chronic liver disease, cirrhosis, and potentially life-threatening complications.
2. **CMV viremia**: The patient's CMV viral load is positive, which can lead to CMV disease, including pneumonitis, colitis, and hepatitis.
3. **Acute renal failure (ARF)**: The patient's creatinine level is increasing, and they have hyperkalemia, which can worsen ARF. The etiology of ARF is unclear, but it may be related to cyclosporine-induced nephrotoxicity, foscarnet, dehydration, chronic diarrhea, or renal GVHD.
4. **Hemolytic anemia**: The patient has low hemoglobin levels, and they are receiving 1-up RBC transfusions. The cause of hemolytic anemia is unclear, but it may be related to GVHD, CMV infection, or other underlying conditions.
5. **Infections**: The patient has a history of recurrent multiple myeloma and has received immunosuppressive therapy, which increases their risk of infection. The patient's low white blood cell count and platelet count also increase their risk of bleeding and infection.
6. **Hypertension**: The patient has hypertension, which can worsen if not controlled.
7. **Diabetes**: The patient has low blood sugar levels despite receiving insulin and total parenteral nutrition (TPN). This may be related to liver dysfunction or other underlying conditions.
8. **Gastrointestinal bleeding**: The patient has persistent bleeding in the stomach and duodenum, which may be related to gastritis, duodenitis, or other underlying conditions.
9. **Fluid overload**: The patient has received a large amount of fluid, which can lead to fluid overload and potentially life-threatening complications.
10. **Pulmonary complications**: The patient has a history of recurrent multiple myeloma and has received immunosuppressive therapy, which increases their risk of pulmonary complications, such as pneumonia or acute respiratory distress syndrome.

Based on the patient's condition, it is essential to continue monitoring their vital signs, laboratory results, and clinical status closely to identify any potential complications early and intervene promptly to prevent adverse outcomes."
116756.0,286913,2167-04-25 06:36:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - STOP [**2167-4-24**] 01:22 PM
 TUNNELED (HICKMAN) LINE - START [**2167-4-24**] 08:54 PM
   - holding acyclovir for now per BMT for bump in creatinine
   - Hct trended down overnight from 29 to 25, getting 1upRBCs now
   - rec'd two bags plts
   - restarted home regimen Ms Contin
   - Liver biopsy final report + GVHD
   - BP poorly controlled, gave IV hydralazine
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-24**] 08:00 PM
   Infusions:
   Other ICU medications:
   Carafate (Sucralfate) - [**2167-4-24**] 08:00 PM
   Other medications:
   Flowsheet Data as of  [**2167-4-25**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 89 (74 - 89) bpm
   BP: 171/115(126) {91/63(70) - 191/153(158)} mmHg
   RR: 28 (9 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  5,070 mL
                                                                  1,199 mL
   PO:
                                                                  1,280 mL
                                                                    350 mL
   TF:
   IVF:
                                                                    618 mL
                                                                     61 mL
   Blood products:
                                                                  1,142 mL
                                                                    277 mL
   Total out:
                                                                  3,455 mL
                                                                  1,520 mL
   Urine:
                                                                  3,455 mL
                                                                  1,520 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,615 mL
                                                                   -321 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Labs / Radiology
   93 K/uL
   10.9 g/dL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   25.4 %
   4.5 K/uL
        [image002.jpg]
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
                             [**2167-4-24**]  08:44 AM
                             [**2167-4-24**]  03:40 PM
                             [**2167-4-24**]  07:27 PM
                             [**2167-4-25**]  12:01 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   5.2
   4.5
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   29.4
   29.7
   27.9
   25.4
   Plt
   57
   46
   130
   107
   86
   58
   52
   39
   63
   93
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: [**2167-4-22**] 4:30 pm TISSUE     Site:
   LIVER      Source: Liver r/o CMV.
      GRAM STAIN (Final [**2167-4-22**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      TISSUE (Preliminary):    NO GROWTH.
      ANAEROBIC CULTURE (Preliminary):    NO GROWTH.
      FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED.
      VIRAL CULTURE (Preliminary):    No Virus isolated so far.
      CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) (Pending):
   Microbiology: CVM VL pending from [**4-23**]
   [**4-22**] liver biopsy:
   Liver, transjugular needle biopsy:
   1.  Mild portal, predominantly mononuclear inflammation with
   lymphocytic bile duct infiltration, associated bile duct damage and
   focal endothelialitis, see note.
   2.  Marked iron deposition in Kupffer cells and mild to moderate iron
   within hepatocytes on special stain; focal associated hepatocyte
   necrosis seen.
   3.  Scattered apoptotic hepatocytes with minimal lobular inflammation;
   no significant steatosis present.
   4.  GMS stain is negative for fungi, with a satisfactory control.
   5.  CMV immunostain is negative for viral inclusions, with a
   satisfactory control.
   6.  Trichrome stain demonstrates minimal portal fibrosis.
   Note:  The biliary features are consistent with acute graft vs. host
   disease. A component of injury related to hemachromatosis is also
   identified
   Assessment and Plan
   54 y.o. M with hx of recurrent multiple myeloma now Day 100 s/p cord
   blood transplant course c/b CMV viremia, ARF, low level hemolysis &
   GVHD in liver & colon
   .
   # s/p transjugular biopsy c/b bleed: pt transferred with HCT drop, CT
   abd showed increasing perihepatic hematoma, hct stable through day but
   trended down in evening from 29 to 25. Receiving 1upRBCs now, plts
   transfused up to 93.
   - f/u post transfusion hct, transfusion goal 27-30
   - serial plts, goal transfusion plt ct>50-75
   - serial abd exams
   - surgery & IR aware (page [**Numeric Identifier 1727**] , Dr. [**Last Name (STitle) 1728**] if needed) no plan for
   acute intervention
   - starting Ms Contin 15mg [**Hospital1 **] with breakthrough morphine prn
   # Multiple myeloma Day 100 s/p Cord Tranplant: recent bone marrow day
   +79 <10% celllular, marked hypoplastic megakaryocytes. Chimerism:
   mostly donor so shouldn't be hemolysing.
   - monitor cell counts - still transfusion dependent (goal plts >50 &
   goal hct >27-30)
   - continue cellcept & methylpred
   - continue cyclosporin [**Month (only) 38**] to 150mg [**Hospital1 **]
   - f/u am cyclopsporin level & adjust prn for approx 200
   .
   # BRBPR/Diarrhea: recent EGD with e/o gastritis/duodenitis, path neg
   for CMV/GVHD. H. pylori Ab+, capsule showed persistent bleeding in SB,
   no intervention at this time per GI.  Pt with persistent diarrhea
   despite increased immunosuppression for presumed GVH.  Currently on TPN
   & clears for bowel rest
   - current regimen of solu-medrol 40mg [**Hospital1 **], cellcept 750mg IV BID,
   cyclosporin 150mg [**Hospital1 **]
   - continue sucralfate, pantoprazole
   - transfusion scales: keep hct>30 and platelets>30
   #Abn LFTs
 most likely etiology GVHD given [**4-22**] liver biopsy positive,
   all viral studies negative ( CMV, HBV, HCV)
   - trend LFTs daily
   - immune suppression per BMT
   # ARF: Cr up slightly from baseline of 1.9 to 2.0. Etiology unclear,
   possibly [**3-7**] tacrolimus, cyclosporin, foscarnet, dehydration [**3-7**]
   chronic diarrhea  & drop in hct.  Creatinine currently trending.... &
   acyclovir held per BMT due to concern for renal toxicity
   -UPEP, SPEP negative.
   -monitor Creatinine, consider urine lytes if trending up
   .
   # CMV Viremia: repeat CMV VL have been negative through [**Month (only) **]/[**Month (only) **], but
   was initally treated with valgancyclovir, then switched to foscarnet
   [**3-7**] renal failure and now recently on acyclovir. Per BMT, holding
   Acyclovir for a few days given slight rise in creatinine, will restart
   on [**4-27**]. ID recommended continuing Acyclovir 400 [**Hospital1 **] for CMV ppx at
   least 1 year
   - CMV VL q5 days - all recent VL negative
   .
   # HTN: slightly hypertensive, gave one time dose of hydralazine & sbp
   dropped to 100s
   - continue Amlodipine 10mg &  Labetalol 400 mg TID
   .
   # Diabetes: Hyperglycemic with steroids
   - Continue ISS and insulin in TPN
   ICU Care
   Nutrition: TPN w/ Lipids - [**2167-4-24**] 06:25 PM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Tunneled (Hickman) Line - [**2167-4-24**] 08:54 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - STOP [**2167-4-24**] 01:22 PM
 TUNNELED (HICKMAN) LINE - START [**2167-4-24**] 08:54 PM
   - holding acyclovir for now per BMT for bump in creatinine
   - Hct trended down overnight from 29 to 25, getting 1upRBCs now
   - rec'd two bags plts
   - restarted home regimen Ms Contin
   - Liver biopsy final report + GVHD
   - BP poorly controlled, gave IV hydralazine
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-24**] 08:00 PM
   Infusions:
   Other ICU medications:
   Carafate (Sucralfate) - [**2167-4-24**] 08:00 PM
   Other medications:
   Flowsheet Data as of  [**2167-4-25**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 89 (74 - 89) bpm
   BP: 171/115(126) {91/63(70) - 191/153(158)} mmHg
   RR: 28 (9 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  5,070 mL
                                                                  1,199 mL
   PO:
                                                                  1,280 mL
                                                                    350 mL
   TF:
   IVF:
                                                                    618 mL
                                                                     61 mL
   Blood products:
                                                                  1,142 mL
                                                                    277 mL
   Total out:
                                                                  3,455 mL
                                                                  1,520 mL
   Urine:
                                                                  3,455 mL
                                                                  1,520 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,615 mL
                                                                   -321 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Labs / Radiology
   93 K/uL
   10.9 g/dL
   99 mg/dL
   2.0 mg/dL
   26 mEq/L
   4.4 mEq/L
   68 mg/dL
   105 mEq/L
   137 mEq/L
   25.4 %
   4.5 K/uL
        [image002.jpg]
                             [**2167-4-23**]  09:27 AM
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
                             [**2167-4-24**]  08:44 AM
                             [**2167-4-24**]  03:40 PM
                             [**2167-4-24**]  07:27 PM
                             [**2167-4-25**]  12:01 AM
   WBC
   3.9
   4.9
   4.8
   4.4
   5.2
   4.5
   Hct
   20.0
   25.5
   18.3
   21.5
   22.6
   27.4
   29.4
   29.7
   27.9
   25.4
   Plt
   57
   46
   130
   107
   86
   58
   52
   39
   63
   93
   Cr
   2.0
   Glucose
   99
   Other labs: PT / PTT / INR:11.8/26.0/1.0, ALT / AST:133/101, Alk Phos /
   T Bili:123/5.0, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.5 mg/dL, Mg++:2.3 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: [**2167-4-22**] 4:30 pm TISSUE     Site:
   LIVER      Source: Liver r/o CMV.
      GRAM STAIN (Final [**2167-4-22**]):
         NO POLYMORPHONUCLEAR LEUKOCYTES SEEN.
         NO MICROORGANISMS SEEN.
      TISSUE (Preliminary):    NO GROWTH.
      ANAEROBIC CULTURE (Preliminary):    NO GROWTH.
      FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED.
      VIRAL CULTURE (Preliminary):    No Virus isolated so far.
      CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) (Pending):
   Microbiology: CVM VL pending from [**4-23**]
   [**4-22**] liver biopsy:
   Liver, transjugular needle biopsy:
   1.  Mild portal, predominantly mononuclear inflammation with
   lymphocytic bile duct infiltration, associated bile duct damage and
   focal endothelialitis, see note.
   2.  Marked iron deposition in Kupffer cells and mild to moderate iron
   within hepatocytes on special stain; focal associated hepatocyte
   necrosis seen.
   3.  Scattered apoptotic hepatocytes with minimal lobular inflammation;
   no significant steatosis present.
   4.  GMS stain is negative for fungi, with a satisfactory control.
   5.  CMV immunostain is negative for viral inclusions, with a
   satisfactory control.
   6.  Trichrome stain demonstrates minimal portal fibrosis.
   Note:  The biliary features are consistent with acute graft vs. host
   disease. A component of injury related to hemachromatosis is also
   identified
   Assessment and Plan
   54 y.o. M with hx of recurrent multiple myeloma now Day 100 s/p cord
   blood transplant course c/b CMV viremia, ARF, low level hemolysis &
   GVHD in liver & colon
   .
   # s/p transjugular biopsy c/b bleed: pt transferred with HCT drop, CT
   abd showed increasing perihepatic hematoma, hct stable through day but
   trended down in evening from 29 to 25. Receiving 1upRBCs now, plts
   transfused up to 93.
   - f/u post transfusion hct, transfusion goal 27-30
   - serial plts, goal transfusion plt ct>50-75
   - serial abd exams
   - surgery & IR aware (page [**Numeric Identifier 1727**] , Dr. [**Last Name (STitle) 1728**] if needed) no plan for
   acute intervention
   - starting Ms Contin 15mg [**Hospital1 **] with breakthrough morphine prn
   # Multiple myeloma Day 100 s/p Cord Tranplant: recent bone marrow day
   +79 <10% celllular, marked hypoplastic megakaryocytes. Chimerism:
   mostly donor so shouldn't be hemolysing.
   - monitor cell counts - still transfusion dependent (goal plts >50 &
   goal hct >27-30)
   - continue cellcept & methylpred
   - continue cyclosporin [**Month (only) 38**] to 150mg [**Hospital1 **]
   - f/u am cyclopsporin level & adjust prn for approx 200
   .
   # BRBPR/Diarrhea: recent EGD with e/o gastritis/duodenitis, path neg
   for CMV/GVHD. H. pylori Ab+, capsule showed persistent bleeding in SB,
   no intervention at this time per GI.  Pt with persistent diarrhea
   despite increased immunosuppression for presumed GVH.  Currently on TPN
   & clears for bowel rest
   - current regimen of solu-medrol 40mg [**Hospital1 **], cellcept 750mg IV BID,
   cyclosporin 150mg [**Hospital1 **]
   - continue sucralfate, pantoprazole
   - transfusion scales: keep hct>30 and platelets>30
   #Abn LFTs
 most likely etiology GVHD given [**4-22**] liver biopsy positive,
   all viral studies negative ( CMV, HBV, HCV)
   - trend LFTs daily
   - immune suppression per BMT
   # ARF: Cr up slightly from baseline of 1.9 to 2.0. Etiology unclear,
   possibly [**3-7**] tacrolimus, cyclosporin, foscarnet, dehydration [**3-7**]
   chronic diarrhea  & drop in hct.  Creatinine currently trending.... &
   acyclovir held per BMT due to concern for renal toxicity
   -UPEP, SPEP negative.
   -monitor Creatinine, consider urine lytes if trending up
   .
   # CMV Viremia: repeat CMV VL have been negative through [**Month (only) **]/[**Month (only) **], but
   was initally treated with valgancyclovir, then switched to foscarnet
   [**3-7**] renal failure and now recently on acyclovir. Per BMT, holding
   Acyclovir for a few days given slight rise in creatinine, will restart
   on [**4-27**]. ID recommended continuing Acyclovir 400 [**Hospital1 **] for CMV ppx at
   least 1 year
   - CMV VL q5 days - all recent VL negative
   .
   # HTN: slightly hypertensive, gave one time dose of hydralazine & sbp
   dropped to 100s
   - continue Amlodipine 10mg &  Labetalol 400 mg TID
   .
   # Diabetes: Hyperglycemic with steroids
   - Continue ISS and insulin in TPN
   ICU Care
   Nutrition: TPN w/ Lipids - [**2167-4-24**] 06:25 PM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Tunneled (Hickman) Line - [**2167-4-24**] 08:54 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following summary and potential medical complications can be identified:

Summary:

The patient is a 54-year-old male with a history of recurrent multiple myeloma who underwent a cord blood transplant 100 days ago. He is experiencing several complications, including:

* CMV viremia, which was initially treated with valgancyclovir, then switched to foscarnet, and now is being held due to concern for renal toxicity
* Acute graft-vs-host disease (GVHD) in the liver and colon, as confirmed by liver biopsy
* Renal failure, with a slight rise in creatinine
* Low-level hemolysis
* Hypertension, which is poorly controlled
* Hyperglycemia, which is being managed with insulin in the total parenteral nutrition (TPN)
* Diarrhea, which is presumed to be related to GVHD and is being managed with bowel rest and immunosuppression

Potential Medical Complications:

1. Increased risk of bleeding due to thrombocytopenia and low hemoglobin levels
2. Increased risk of infection due to immunosuppression and GVHD
3. Increased risk of renal failure due to continued use of nephrotoxic medications such as foscarnet and cyclosporin
4. Increased risk of liver failure due to ongoing GVHD and potential complications from the liver biopsy
5. Increased risk of cardiac complications due to hypertension and potential effects of immunosuppressive medications
6. Increased risk of gastrointestinal complications due to diarrhea and potential effects of immunosuppressive medications
7. Increased risk of metabolic complications due to hyperglycemia and potential effects of immunosuppressive medications

Recommendations:

1. Continue to monitor the patient's platelet count and hemoglobin levels closely to ensure that they remain within safe ranges.
2. Continue to monitor the patient's renal function closely and adjust his medications as necessary to minimize the risk of further renal damage.
3. Continue to monitor the patient's liver function closely and adjust his medications as necessary to minimize the risk of further liver damage.
4. Continue to monitor the patient's blood pressure closely and adjust his medications as necessary to minimize the risk of cardiac complications.
5. Continue to monitor the patient's blood glucose levels closely and adjust his insulin regimen as necessary to minimize the risk of further hyperglycemia.
6. Consider further evaluation and treatment of the patient's diarrhea, including potential endoscopy and biopsy to rule out other causes of diarrhea.
7. Consider further evaluation and treatment of the patient's CMV viremia, including potential antiviral therapy and monitoring of his CMV viral load."
116756.0,286913,2167-04-25 10:07:00,Physician ,Physician Attending Progress Note,"Chief Complaint:
   I saw and examined the patient, and was physically present with the
   for key portions of the services provided.  I agree with his / her note
   above, including assessment and plan.
   HPI:
   24 Hour Events:
   Acyclovir held due to increase in creatinine. CMV titer increased
   Liver bx reported as definite GVHD
   Transfused 1 unit PRBC for Hct decrease to 25
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-24**] 08:00 PM
   Infusions:
   Other ICU medications:
   Carafate (Sucralfate) - [**2167-4-24**] 08:00 PM
   Dextrose 50% - [**2167-4-25**] 08:15 AM
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Cough
   Gastrointestinal: No(t) Abdominal pain
   Flowsheet Data as of  [**2167-4-25**] 10:06 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.8
C (98.3
   HR: 86 (74 - 98) bpm
   BP: 147/91(105) {91/63(70) - 191/153(158)} mmHg
   RR: 17 (9 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  5,070 mL
                                                                  1,562 mL
   PO:
                                                                  1,280 mL
                                                                    350 mL
   TF:
   IVF:
                                                                    618 mL
                                                                     97 mL
   Blood products:
                                                                  1,142 mL
                                                                    277 mL
   Total out:
                                                                  3,455 mL
                                                                  2,320 mL
   Urine:
                                                                  3,455 mL
                                                                  2,320 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,615 mL
                                                                   -758 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///28/
   Physical Examination
   General Appearance: Overweight / Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Distant), (Murmur: No(t) Systolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Extremities: Right: 1+, Left: 1+
   Skin:  Warm, jaundice
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.4 g/dL
   54 K/uL
   262 mg/dL
   2.1 mg/dL
   28 mEq/L
   5.5 mEq/L
   70 mg/dL
   102 mEq/L
   138 mEq/L
   27.5 %
   4.1 K/uL
        [image002.jpg]
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
                             [**2167-4-24**]  08:44 AM
                             [**2167-4-24**]  03:40 PM
                             [**2167-4-24**]  07:27 PM
                             [**2167-4-25**]  12:01 AM
                             [**2167-4-25**]  05:43 AM
   WBC
   4.9
   4.8
   4.4
   5.2
   4.5
   4.1
   Hct
   25.5
   18.3
   21.5
   22.6
   27.4
   29.4
   29.7
   27.9
   25.4
   27.5
   Plt
   46
   130
   107
   86
   58
   52
   39
   63
   93
   54
   Cr
   2.0
   2.1
   Glucose
   99
   262
   Other labs: PT / PTT / INR:11.8/24.6/1.0, ALT / AST:158/115, Alk Phos /
   T Bili:134/6.2, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.8 mg/dL, Mg++:2.6 mg/dL, PO4:3.4 mg/dL
   Assessment and Plan
   54 yr old s/p cord blood transplant d 99, course complicated by CMV
   viremia and now GVHD.
   S/p transjugular biopsy complicated by acute bleed.
   1. Acute bleeding - in setting of transjugular bx with refractory
   thrombocytopenia. Will need to keep platelets > 50 until Hct
   stabilizes.  Check hct [**5-10**] h for now. Aim for Hct ~23. Finally seems to
   be stabilizing.
   2. GVHD - on steroids, on cellcept, cyclo. On caspo for hx of fungal
   infection. Cyclo level 200, will touch base with heme about lowering
   goal given renal status
   3. Thrombocytopenia - multifactorial, keep > 50K
   4. CMV viremia - most recent viral load negative on [**4-21**], but 800
   copies on [**4-23**] titer.
   Acyclovir was held for increase in creatinine but that is less likely
   to be the culprit. Will give acyclovir this AM and discuss with ID.
   5. ARF - making urine, lytes ok. Etiology unclear, cyclosporine levels
   vs less likely acyclovir.
   6. HTN - stable, on norvasc, labetolol
   7. ID issues - low grade temps, no evidence of pneumonia. D/c levoflox.
   F/u cultures, so far negative.
   8. Pain control
 on MS contin.  Will d/c ativan.
   9. FEN - on TPN. Reduce insulin.
   Stable to transfer to floor
   ICU Care
   Nutrition:
   TPN w/ Lipids - [**2167-4-25**] 06:03 AM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Tunneled (Hickman) Line - [**2167-4-24**] 08:54 PM
   Prophylaxis:
   DVT: Boots
   Comments:
   Communication: ICU consent signed, Code status: Full code, Disposition
   :Transfer to floor, Total time spent: 30 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   I saw and examined the patient, and was physically present with the
   for key portions of the services provided.  I agree with his / her note
   above, including assessment and plan.
   HPI:
   24 Hour Events:
   Acyclovir held due to increase in creatinine. CMV titer increased
   Liver bx reported as definite GVHD
   Transfused 1 unit PRBC for Hct decrease to 25
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Caspofungin - [**2167-4-24**] 08:00 PM
   Infusions:
   Other ICU medications:
   Carafate (Sucralfate) - [**2167-4-24**] 08:00 PM
   Dextrose 50% - [**2167-4-25**] 08:15 AM
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Cardiovascular: No(t) Chest pain
   Respiratory: No(t) Cough
   Gastrointestinal: No(t) Abdominal pain
   Flowsheet Data as of  [**2167-4-25**] 10:06 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.8
C (98.3
   HR: 86 (74 - 98) bpm
   BP: 147/91(105) {91/63(70) - 191/153(158)} mmHg
   RR: 17 (9 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
           Total In:
                                                                  5,070 mL
                                                                  1,562 mL
   PO:
                                                                  1,280 mL
                                                                    350 mL
   TF:
   IVF:
                                                                    618 mL
                                                                     97 mL
   Blood products:
                                                                  1,142 mL
                                                                    277 mL
   Total out:
                                                                  3,455 mL
                                                                  2,320 mL
   Urine:
                                                                  3,455 mL
                                                                  2,320 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  1,615 mL
                                                                   -758 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///28/
   Physical Examination
   General Appearance: Overweight / Obese
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Distant), (Murmur: No(t) Systolic)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Extremities: Right: 1+, Left: 1+
   Skin:  Warm, jaundice
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.4 g/dL
   54 K/uL
   262 mg/dL
   2.1 mg/dL
   28 mEq/L
   5.5 mEq/L
   70 mg/dL
   102 mEq/L
   138 mEq/L
   27.5 %
   4.1 K/uL
        [image002.jpg]
                             [**2167-4-23**]  12:25 PM
                             [**2167-4-23**]  04:34 PM
                             [**2167-4-23**]  06:53 PM
                             [**2167-4-23**]  08:48 PM
                             [**2167-4-24**]  03:32 AM
                             [**2167-4-24**]  08:44 AM
                             [**2167-4-24**]  03:40 PM
                             [**2167-4-24**]  07:27 PM
                             [**2167-4-25**]  12:01 AM
                             [**2167-4-25**]  05:43 AM
   WBC
   4.9
   4.8
   4.4
   5.2
   4.5
   4.1
   Hct
   25.5
   18.3
   21.5
   22.6
   27.4
   29.4
   29.7
   27.9
   25.4
   27.5
   Plt
   46
   130
   107
   86
   58
   52
   39
   63
   93
   54
   Cr
   2.0
   2.1
   Glucose
   99
   262
   Other labs: PT / PTT / INR:11.8/24.6/1.0, ALT / AST:158/115, Alk Phos /
   T Bili:134/6.2, Fibrinogen:291 mg/dL, Albumin:3.0 g/dL, LDH:780 IU/L,
   Ca++:8.8 mg/dL, Mg++:2.6 mg/dL, PO4:3.4 mg/dL
   Assessment and Plan
   54 yr old s/p cord blood transplant d 99, course complicated by CMV
   viremia and now GVHD.
   S/p transjugular biopsy complicated by acute bleed.
   1. Acute bleeding - in setting of transjugular bx with refractory
   thrombocytopenia. Will need to keep platelets > 50 until Hct
   stabilizes.  Check hct [**5-10**] h for now. Aim for Hct ~23. Finally seems to
   be stabilizing.
   2. GVHD - on steroids, on cellcept, cyclo. On caspo for hx of fungal
   infection. Cyclo level 200, will touch base with heme about lowering
   goal given renal status
   3. Thrombocytopenia - multifactorial, keep > 50K
   4. CMV viremia - most recent viral load negative on [**4-21**], but 800
   copies on [**4-23**] titer.
   Acyclovir was held for increase in creatinine but that is less likely
   to be the culprit. Will give acyclovir this AM and discuss with ID.
   5. ARF - making urine, lytes ok. Etiology unclear, cyclosporine levels
   vs less likely acyclovir.
   6. HTN - stable, on norvasc, labetolol
   7. ID issues - low grade temps, no evidence of pneumonia. D/c levoflox.
   F/u cultures, so far negative.
   8. Pain control
 on MS contin.  Will d/c ativan.
   9. FEN - on TPN. Reduce insulin.
   Stable to transfer to floor
   ICU Care
   Nutrition:
   TPN w/ Lipids - [**2167-4-25**] 06:03 AM 84 mL/hour
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Tunneled (Hickman) Line - [**2167-4-24**] 08:54 PM
   Prophylaxis:
   DVT: Boots
   Comments:
   Communication: ICU consent signed, Code status: Full code, Disposition
   :Transfer to floor, Total time spent: 30 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 54-year-old male who underwent cord blood transplant 99 days ago, complicated by CMV viremia and now GVHD. The patient has had an acute bleed following a transjugular biopsy, resulting in refractory thrombocytopenia. The patient's platelet count is currently 54 K/uL, and the goal is to keep it above 50 K until the hemoglobin (Hct) stabilizes. The patient is also experiencing GVHD, which is being treated with steroids, Cellcept, and cyclosporine. The patient has a history of fungal infection and is receiving caspofungin.

The patient's renal function is compromised, with a creatinine level of 2.0 mg/dL. The patient is making urine, but the etiology of acute renal failure (ARF) is unclear. The patient's blood pressure is stable, and they are being treated with norvasc and labetolol.

The patient has low-grade temperatures, but no evidence of pneumonia. Cultures have been sent, and so far, they have been negative. The patient is receiving TPN and has been stabilized on insulin. The patient's pain is being controlled with MS contin, and they are being weaned off ativan.

Potential Medical Complications:

1. Bleeding complications: The patient's thrombocytopenia and recent acute bleed make them at risk for further bleeding complications.
2. GVHD: The patient's GVHD is being treated, but it is a potentially life-threatening complication of the transplant.
3. Renal failure: The patient's compromised renal function increases their risk for further kidney damage or failure.
4. Infection: The patient's compromised immune system and history of fungal infection make them at risk for infection.
5. Hypoglycemia: The patient's insulin therapy and TPN make them at risk for hypoglycemia.
6. Hypertension: The patient's hypertension is being treated, but it is a potential complication that could worsen if not managed properly.
7. Pain management: The patient's pain is being controlled, but it is a potential complication that could worsen if not managed properly."
